export const vaccines = [
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Ad26.COV2-S (or JNJ-78436725), Non repli… [+51]",
        "developerResearcher": "Janssen Pharmaceutical Companies/ Beth I… [+134]",
        "funder": "Biomedical Advanced Research and Develop… [+22]",
        "lastUpdated": "2021-12-09T00:00:00.000Z",
        "nextSteps": "Health Canada fully \"approved\" the vacci… [+2173]",
        "phase": "Authorized",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "janssen-pharmaceutical-companies-beth-israel-deaconess-medical-center-emergent-biosolutions-catalent-biological-e-grand-river-aseptic-manufacturing-(gram)-sanofi-merck"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "T cell-based vaccine platform (CoVepiT)",
        "developerResearcher": "OSE  Immunotherapeutics/ Cenexi",
        "funder": "undefined",
        "lastUpdated": "2021-12-09T00:00:00.000Z",
        "nextSteps": "First positive results announced 11/30/2… [+114]",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "ose-immunotherapeutics-cenexi"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "PTX-COVID19-B vaccine",
        "developerResearcher": "Providence Therapeutics Holdings Inc.",
        "funder": "undefined",
        "lastUpdated": "2021-12-09T00:00:00.000Z",
        "nextSteps": "Phase II expected to begin June 2021; Pr… [+105]",
        "phase": "Phase I",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "providence-therapeutics-holdings-inc."
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, capsid-like particle (C… [+14]",
        "developerResearcher": "AdaptVac (PREVENT-nCoV consortium)",
        "funder": "European Commission (Horizon 2020 Progra… [+2]",
        "lastUpdated": "2021-12-09T00:00:00.000Z",
        "nextSteps": "Phase I/II (COUGH-1) study began March 2… [+99]",
        "phase": "Phase II",
        "trimedCategory": "protein-subunit",
        "trimedName": "adaptvac-(prevent-ncov-consortium)"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; LNP-encapsulated (mRNA-1273.529)",
        "developerResearcher": "ModernaTX, Inc.",
        "funder": "undefined",
        "lastUpdated": "2021-12-03T00:00:00.000Z",
        "nextSteps": "Rapidly advancing an Omicron-specific bo… [+48]",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "modernatx-inc."
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "LNP-mRNA; (ChulaCov19)",
        "developerResearcher": "Chulalongkorn University/ Chula Vaccine … [+42]",
        "funder": "undefined",
        "lastUpdated": "2021-12-03T00:00:00.000Z",
        "nextSteps": "Phase II began August 2021; Phase I bega… [+11]",
        "phase": "Phase I/II",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "chulalongkorn-university-chula-vaccine-research-centeruniversity-of-pennsylvania"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Plant-based subunit (RBD-Fc + Adjuvant)",
        "developerResearcher": "Baiya Phytopharm/ Chula Vaccine Research… [+7]",
        "funder": "undefined",
        "lastUpdated": "2021-12-03T00:00:00.000Z",
        "nextSteps": "Phase I began September 2021; Animal tri… [+35]",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "baiya-phytopharm-chula-vaccine-research-center"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "rVSV-SARS-CoV-2-S vaccine; (BriLife)",
        "developerResearcher": "Israel\n  Institute for Biological Resear… [+33]",
        "funder": "undefined",
        "lastUpdated": "2021-12-03T00:00:00.000Z",
        "nextSteps": "Phase IIb/III expected to begin Septembe… [+110]",
        "phase": "Phase I/II",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "israel-institute-for-biological-research-weizmann-institute-of-science"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "Next-generation multi-valent mRNA-based … [+17]",
        "developerResearcher": "GlaxoSmithKline/CureVac",
        "funder": "undefined",
        "lastUpdated": "2021-11-29T00:00:00.000Z",
        "nextSteps": "Pre-clinical data published 11/18/2021; … [+280]",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "glaxosmithklinecurevac"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "T-Cell Priming Peptide Vaccine Against C… [+33]",
        "developerResearcher": "Emergex Vaccines Holdings/ Center for Pr… [+110]",
        "funder": "undefined",
        "lastUpdated": "2021-11-29T00:00:00.000Z",
        "nextSteps": "Phase I (Stage II of a 2-part adaptive t… [+83]",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "emergex-vaccines-holdings-center-for-primary-care-and-public-health-(unisante)-university-of-lausanne-switzerland-university-of-lausanne-hospitals"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "SARS-CoV-2 Protein Subunit Recombinant V… [+6]",
        "developerResearcher": "PT Bio Farma",
        "funder": "undefined",
        "lastUpdated": "2021-11-29T00:00:00.000Z",
        "nextSteps": "Phase  I/II expected to begin November 2… [+3]",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "pt-bio-farma"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "SARS-CoV-2 DNA Vaccine Delivered Intramu… [+36]",
        "developerResearcher": "The University of Hong Kong/ Immuno Cure… [+10]",
        "funder": "undefined",
        "lastUpdated": "2021-11-29T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin November 2021",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "the-university-of-hong-kong-immuno-cure-3-limited"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Ad5-triCoV/Mac or ChAd-triCoV/Mac, new e… [+107]",
        "developerResearcher": "McMaster University/ Canadian Institutes… [+26]",
        "funder": "undefined",
        "lastUpdated": "2021-11-29T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin November 2021",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "mcmaster-university-canadian-institutes-of-health-research-(cihr)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "SARS-CoV-2 Vaccine, (IN-B009)",
        "developerResearcher": "HK inno.N Corporation (formerly CJ Healt… [+6]",
        "funder": "undefined",
        "lastUpdated": "2021-11-29T00:00:00.000Z",
        "nextSteps": "Phase I began September 2021",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "hk-inno.n-corporation-(formerly-cj-healthcare)"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; mRNA (DS-5670)",
        "developerResearcher": "Daiichi-Sankyo/ University of Tokyo's In… [+26]",
        "funder": "undefined",
        "lastUpdated": "2021-11-29T00:00:00.000Z",
        "nextSteps": "Phase II segment of I/II clinical trial … [+76]",
        "phase": "Phase I/II",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "daiichi-sankyo-university-of-tokyos-institute-of-medical-science"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated; whole-virion (COVAXIN) (BBV… [+4]",
        "developerResearcher": "Bharat Biotech/ Indian Council of Medica… [+72]",
        "funder": "undefined",
        "lastUpdated": "2021-11-28T00:00:00.000Z",
        "nextSteps": "World Health Organization (WHO) granted … [+799]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "bharat-biotech-indian-council-of-medical-research-national-institute-of-virology-ocugen-precisa-medicamentos"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "SARS-CoV-2 recombinant protein nanoparti… [+21]",
        "developerResearcher": "SK bioscience/ GSK/ Institute for Protei… [+51]",
        "funder": "Gates Foundation/ Coalition for Epidemic… [+20]",
        "lastUpdated": "2021-11-28T00:00:00.000Z",
        "nextSteps": "Phase I/II final data announced November… [+169]",
        "phase": "Phase I/II",
        "trimedCategory": "protein-subunit",
        "trimedName": "sk-bioscience-gsk-institute-for-protein-design-(ipd)-at-the-university-of-washington-(uw)"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (INO-4800) plasmid vaccine with ele… [+12]",
        "developerResearcher": "Inovio Pharmaceuticals/ Beijing Advaccin… [+183]",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+48]",
        "lastUpdated": "2021-11-28T00:00:00.000Z",
        "nextSteps": "Phase III segment of INNOVATE trial has … [+1011]",
        "phase": "Phase II/III",
        "trimedCategory": "dna-based",
        "trimedName": "inovio-pharmaceuticals-beijing-advaccine-biotechnology-vgxi-inc.-richter-helm-biologics-ology-bioservices-international-vaccine-institute-seoul-national-university-hospital-thermo-fisher-scientific-kaneka-eurogentec"
    },
    {
        "FDAApproved": "undefined",
        "category": "Live attenuated virus",
        "description": "Intranasal live-attenuated chimeric vacc… [+27]",
        "developerResearcher": "Meissa Vaccines",
        "funder": "undefined",
        "lastUpdated": "2021-11-28T00:00:00.000Z",
        "nextSteps": "Preliminary clinical data on safety and … [+113]",
        "phase": "Phase I",
        "trimedCategory": "live-attenuated-virus",
        "trimedName": "meissa-vaccines"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "COVID-19 inactivated vaccine (COVIran Ba… [+6]",
        "developerResearcher": "Shifa Pharmed Industrial Co",
        "funder": "undefined",
        "lastUpdated": "2021-11-28T00:00:00.000Z",
        "nextSteps": "Phase I study in children ages 12-18 beg… [+262]",
        "phase": "Phase II/III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "shifa-pharmed-industrial-co"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non replicating viral vector; COVID-19 V… [+95]",
        "developerResearcher": "University of Oxford, Oxford Biomedica, … [+187]",
        "funder": "Coalition for Epidemic Preparedness Inno… [+121]",
        "lastUpdated": "2021-11-28T00:00:00.000Z",
        "nextSteps": "Phase III safety and efficacy data publi… [+2147]",
        "phase": "Authorized",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "university-of-oxford-oxford-biomedica,-vaccines-manufacturing-and-innovation-centre,-pall-life-sciences,-cobra-biologics,-halixbv,-advent-s.r.l.,-merck-kgaa,-the-serum-institute,-vaccitech,-catalent,-csl,-and-astrazenecaiqvia"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "SARS-CoV-2 recombinant Spike protein vac… [+20]",
        "developerResearcher": "Razi Vaccine and Serum Research Institut… [+1]",
        "funder": "undefined",
        "lastUpdated": "2021-11-28T00:00:00.000Z",
        "nextSteps": "Iran issued an emergency use license in … [+101]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "razi-vaccine-and-serum-research-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated SARS-CoV-2 vaccine, Vero cel… [+12]",
        "developerResearcher": "Shenzhen Kangtai Biological Products Co.… [+45]",
        "funder": "undefined",
        "lastUpdated": "2021-11-28T00:00:00.000Z",
        "nextSteps": "Indonesia granted \"emergency use authori… [+195]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "shenzhen-kangtai-biological-products-co.-ltd.-beijing-minhai-biotechnology-co.,-ltd."
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "Second-generation DNA plasmid vaccine, R… [+18]",
        "developerResearcher": "Vaccibody\n  AS",
        "funder": "undefined",
        "lastUpdated": "2021-10-29T00:00:00.000Z",
        "nextSteps": "Phase I/II began October 2021",
        "phase": "Phase I/II",
        "trimedCategory": "dna-based",
        "trimedName": "vaccibody-as"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "MVC-COV1901 vaccine injection; S-2 P pro… [+15]",
        "developerResearcher": "Medigen Vaccine Biologics Corp/ NIAID/ D… [+6]",
        "funder": "undefined",
        "lastUpdated": "2021-10-29T00:00:00.000Z",
        "nextSteps": "Announced (10/26/2021) as one of two can… [+893]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "medigen-vaccine-biologics-corp-niaid-dynavax"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "Second generation DNA plasmid vaccine, T… [+21]",
        "developerResearcher": "Vaccibody AS",
        "funder": "undefined",
        "lastUpdated": "2021-10-29T00:00:00.000Z",
        "nextSteps": "Phase I/II began October 2021",
        "phase": "Phase I/II",
        "trimedCategory": "dna-based",
        "trimedName": "vaccibody-as"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; recombinant spike prote… [+45]",
        "developerResearcher": "Vaxine Pty Ltd/ Flinders University/ Ora… [+54]",
        "funder": "Innovate UK/ Australian Government",
        "lastUpdated": "2021-10-29T00:00:00.000Z",
        "nextSteps": "Iran issued an emergency use permit in O… [+195]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "vaxine-pty-ltd-flinders-university-oracle-medytox-sypharma-oxford-expression-technologies"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "PIKA-Adjuvanted Recombinant SARS-CoV-2 S… [+32]",
        "developerResearcher": "Yisheng Biopharma",
        "funder": "undefined",
        "lastUpdated": "2021-10-29T00:00:00.000Z",
        "nextSteps": "Phase I clinical trial registered August… [+45]",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "yisheng-biopharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; plasmid vaccine RBD\u0026N",
        "developerResearcher": "Scancell/ University of Nottingham/ Nott… [+23]",
        "funder": "undefined",
        "lastUpdated": "2021-10-29T00:00:00.000Z",
        "nextSteps": "Phase I COVIDITY clinical trial dosed Oc… [+10]",
        "phase": "Phase I",
        "trimedCategory": "dna-based",
        "trimedName": "scancell-university-of-nottingham-nottingham-trent-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant protein vaccine S-268019, ba… [+20]",
        "developerResearcher": "Shionogi \u0026 Co., Ltd./ National Institute… [+29]",
        "funder": "Japan Agency for Medical Research and De… [+9]",
        "lastUpdated": "2021-10-27T00:00:00.000Z",
        "nextSteps": "Phase II/III began October 2021; New Pha… [+206]",
        "phase": "Phase II/III",
        "trimedCategory": "protein-subunit",
        "trimedName": "shionogi-\u0026-co.-ltd.-national-institute-of-infectious-disease,-japan"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "srRNA (EXG-5003)",
        "developerResearcher": "Elixirgen Therapeutics/ Fujita Health Un… [+8]",
        "funder": "Japan Agency for Medical Research and De… [+16]",
        "lastUpdated": "2021-10-27T00:00:00.000Z",
        "nextSteps": "Entered into an exclusive licensing agre… [+149]",
        "phase": "Phase I/II",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "elixirgen-therapeutics-fujita-health-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; LNP-encapsulated mRNA (mRNA 1273), … [+33]",
        "developerResearcher": "Moderna/ National Institute of Allergy a… [+183]",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+66]",
        "lastUpdated": "2021-10-26T00:00:00.000Z",
        "nextSteps": "Phase II/III KidCOVE study positive inte… [+3480]",
        "phase": "Authorized",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "moderna-national-institute-of-allergy-and-infectious-diseases-(niaid)-biomedical-advanced-research-and-development-authority-(barda)-lonza-catalent-rovi-medidata-bioqual-baxter-biopharma-solutions-sanofi-recipharm"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated (Inactivated + CpG 1018), VL… [+5]",
        "developerResearcher": "Valneva/ Dynavax/ National Institute for… [+32]",
        "funder": "undefined",
        "lastUpdated": "2021-10-26T00:00:00.000Z",
        "nextSteps": "Phase III positive topline results annou… [+370]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "valneva-dynavax-national-institute-for-health-research-united-kingdom"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; Oral Vacci… [+12]",
        "developerResearcher": "Vaxart/ Emergent BioSolutions",
        "funder": "undefined",
        "lastUpdated": "2021-10-26T00:00:00.000Z",
        "nextSteps": "Phase II dosed October 2021; Phase I pre… [+285]",
        "phase": "Phase II",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "vaxart-emergent-biosolutions"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "AdCLD-CoV19",
        "developerResearcher": "Cellid\n  Co., Ltd./IAVI",
        "funder": "undefined",
        "lastUpdated": "2021-09-29T00:00:00.000Z",
        "nextSteps": "Phase I study of a revised version of th… [+137]",
        "phase": "Phase I/II",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "cellid-co.-ltd.iavi"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD + adjuvant booster dose that contain… [+42]",
        "developerResearcher": "Instituto Finlay de Vacunas",
        "funder": "undefined",
        "lastUpdated": "2021-09-29T00:00:00.000Z",
        "nextSteps": "Cuba granted emergency use authorization… [+235]",
        "phase": "Phase II",
        "trimedCategory": "protein-subunit",
        "trimedName": "instituto-finlay-de-vacunas"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant Protein RBD",
        "developerResearcher": "Laboratorios Hipra, S.A.",
        "funder": "undefined",
        "lastUpdated": "2021-09-29T00:00:00.000Z",
        "nextSteps": "Phase I/II began August 2021",
        "phase": "Phase I/II",
        "trimedCategory": "protein-subunit",
        "trimedName": "laboratorios-hipra-s.a."
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; (BECOV2)",
        "developerResearcher": "Biological E Ltd/ Dynavax/ Baylor Colleg… [+13]",
        "funder": "Coalition for Epidemic Preparedness Inno… [+14]",
        "lastUpdated": "2021-09-29T00:00:00.000Z",
        "nextSteps": "Phase III began September 2021; Phase II… [+171]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "biological-e-ltd-dynavax-baylor-college-of-medicine"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Bivalent Recombinant Trimeric S Protein … [+46]",
        "developerResearcher": "Sinocelltech Ltd.",
        "funder": "undefined",
        "lastUpdated": "2021-09-29T00:00:00.000Z",
        "nextSteps": "Phase I/II/III, multicenter, randomized,… [+281]",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "sinocelltech-ltd."
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Recombinant Viral Vector AAV5 (Adeno-Ass… [+72]",
        "developerResearcher": "BIOCAD",
        "funder": "undefined",
        "lastUpdated": "2021-09-29T00:00:00.000Z",
        "nextSteps": "Phase I/II began August 2021",
        "phase": "Phase I/II",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "biocad"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated",
        "developerResearcher": "Kocak Farma Ilac ve Kimya San. A.S.",
        "funder": "undefined",
        "lastUpdated": "2021-09-29T00:00:00.000Z",
        "nextSteps": "Phase III began June 2021; Phase I began… [+11]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "kocak-farma-ilac-ve-kimya-san.-a.s."
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, native like trimeric su… [+31]",
        "developerResearcher": "Clover Biopharmaceuticals Inc./ Dynavax",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+2]",
        "lastUpdated": "2021-09-28T00:00:00.000Z",
        "nextSteps": " Phase II/III (SPECTRA) trial succesfull… [+660]",
        "phase": "Phase II/III",
        "trimedCategory": "protein-subunit",
        "trimedName": "clover-biopharmaceuticals-inc.-dynavax"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; mRNA; (LUNAR-COV19), (ARCT-021)",
        "developerResearcher": "Arcturus/Duke-NUS/ Catalent\n",
        "funder": "undefined",
        "lastUpdated": "2021-09-28T00:00:00.000Z",
        "nextSteps": "Emergency Use Authorization filing in Vi… [+608]",
        "phase": "Phase II",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "arcturusduke-nus-catalent-"
    },
    {
        "FDAApproved": "undefined",
        "category": "Live attenuated virus",
        "description": "Single-dose, intranasal, live attenuated… [+20]",
        "developerResearcher": "Codagenix / Serum Institute of India",
        "funder": "undefined",
        "lastUpdated": "2021-09-28T00:00:00.000Z",
        "nextSteps": "Phase I topline safety and immunogenicit… [+234]",
        "phase": "Phase I",
        "trimedCategory": "live-attenuated-virus",
        "trimedName": "codagenix-serum-institute-of-india"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Dendritic cell vaccine AV-COVID-19",
        "developerResearcher": "Aivita Biomedical, Inc./ National Instit… [+80]",
        "funder": "undefined",
        "lastUpdated": "2021-09-28T00:00:00.000Z",
        "nextSteps": "Phase II began February 2021; Phase I be… [+17]",
        "phase": "Phase II",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "aivita-biomedical-inc.-national-institute-of-health-research-and-development,-ministry-of-health-republic-of-indonesia"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (ZyCoV-D) plasmid vaccine",
        "developerResearcher": "Zydus Cadila Healthcare Limited",
        "funder": "undefined",
        "lastUpdated": "2021-08-31T00:00:00.000Z",
        "nextSteps": "India granted \"emergency use approval\" f… [+447]",
        "phase": "Phase III",
        "trimedCategory": "dna-based",
        "trimedName": "zydus-cadila-healthcare-limited"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Intranasal PIV5-vectored vaccine express… [+42]",
        "developerResearcher": "CyanVac LLC",
        "funder": "undefined",
        "lastUpdated": "2021-08-31T00:00:00.000Z",
        "nextSteps": "Phase I began August 2021",
        "phase": "Phase I",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "cyanvac-llc"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "rRBD produced in CHO-cell chemically con… [+73]",
        "developerResearcher": "Instituto Finlay de Vacunas",
        "funder": "undefined",
        "lastUpdated": "2021-08-31T00:00:00.000Z",
        "nextSteps": "Cuba granted \"emergency approval\" on 8/2… [+381]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "instituto-finlay-de-vacunas"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "Self-amplifying mRNA vaccine; (HGCO19)",
        "developerResearcher": "Gennova/ HDT Biotech Corporation",
        "funder": "undefined",
        "lastUpdated": "2021-08-31T00:00:00.000Z",
        "nextSteps": "Mid-stage trials expected to begin Septe… [+38]",
        "phase": "Phase I/II",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "gennova-hdt-biotech-corporation"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Adjuvanted recombinant SARS-CoV-2 trimer… [+64]",
        "developerResearcher": "Clover Biopharmaceuticals AUS Pty Ltd",
        "funder": "undefined",
        "lastUpdated": "2021-08-31T00:00:00.000Z",
        "nextSteps": "Phase II expected to begin August 2021; … [+36]",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "clover-biopharmaceuticals-aus-pty-ltd"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "MVA-based SARS-CoV-2 vaccine; (COH04S1)",
        "developerResearcher": "City of\n  Hope Medical Center",
        "funder": "undefined",
        "lastUpdated": "2021-08-03T00:00:00.000Z",
        "nextSteps": "Phase II expected to begin August 2021; … [+27]",
        "phase": "Phase I",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "city-of-hope-medical-center"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "S1-RBD-protein; Multitope Peptide-Based … [+21]",
        "developerResearcher": "Vaxxinity, Inc. (formerly COVAXX and Uni… [+98]",
        "funder": "Ministry of Health and Welfare in Taiwan… [+0]",
        "lastUpdated": "2021-08-03T00:00:00.000Z",
        "nextSteps": "Phase I study extended with one booster … [+425]",
        "phase": "Phase II",
        "trimedCategory": "protein-subunit",
        "trimedName": "vaxxinity-inc.-(formerly-covaxx-and-united-neuroscience)-university-of-nebraska-medical-center-(unmc)-dasa-united-biomedical-inc.-asia"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; MVA-S enco… [+3]",
        "developerResearcher": "German Center for Infection Research (DZ… [+148]",
        "funder": "undefined",
        "lastUpdated": "2021-07-29T00:00:00.000Z",
        "nextSteps": "Spike protein of the vector vaccine has … [+216]",
        "phase": "Phase I",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "german-center-for-infection-research-(dzif)-idt-biologika-gmbh-universitätsklinikum-hamburg-eppendorf-philipps-university-marburg-medical-center-ludwig-maximilians-university-of-munich"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (COVIGEN) needle-free delivery",
        "developerResearcher": "BioNet Asia/ Technovalia/ Vax4COVID/ The… [+94]",
        "funder": "Australian Government Medical Research F… [+17]",
        "lastUpdated": "2021-07-29T00:00:00.000Z",
        "nextSteps": "Phase I dosed end of June 2021",
        "phase": "Phase I",
        "trimedCategory": "dna-based",
        "trimedName": "bionet-asia-technovalia-vax4covid-the-university-of-sydney-the-university-of-western-australia-telethon-kids-institute-pharmajet"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; (AZD2816)",
        "developerResearcher": "AstraZeneca",
        "funder": "undefined",
        "lastUpdated": "2021-07-29T00:00:00.000Z",
        "nextSteps": "Phase II/III dosed end of June 2021, in … [+245]",
        "phase": "Phase II/III",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "astrazeneca"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "mRNA second generation COVID-19 vaccine",
        "developerResearcher": "Monash Institute of Pharmaceutical Scien… [+82]",
        "funder": "mRNA Victoria, the agency of the Austral… [+32]",
        "lastUpdated": "2021-07-29T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin October 2021; … [+64]",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "monash-institute-of-pharmaceutical-sciences-(mips)-peter-doherty-institute-for-infection-and-immunity-(doherty-institute)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; S protein, baculovirus … [+24]",
        "developerResearcher": "Sanofi Pasteur/ GSK",
        "funder": "Biomedical Advanced Research and Develop… [+104]",
        "lastUpdated": "2021-07-29T00:00:00.000Z",
        "nextSteps": "EMA began rolling review on 7/20/2021; P… [+426]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "sanofi-pasteur-gsk"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; [E1-, E2b-… [+85]",
        "developerResearcher": "ImmunityBio/ NantKwest",
        "funder": "undefined",
        "lastUpdated": "2021-07-19T00:00:00.000Z",
        "nextSteps": "Phase I/II/III trial expected to begin Q… [+992]",
        "phase": "Phase I/II",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "immunitybio-nantkwest"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; replicatio… [+63]",
        "developerResearcher": "ReiThera/ Leukocare/ Univercells/ Nation… [+55]",
        "funder": "undefined",
        "lastUpdated": "2021-07-19T00:00:00.000Z",
        "nextSteps": "Phase II preliminary data announced July… [+270]",
        "phase": "Phase II/III",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "reithera-leukocare-univercells-national-institute-of-infectious-diseases-lazzaro-spallanzani"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (GLS-5310)",
        "developerResearcher": "GeneOne\n  Life Science",
        "funder": "undefined",
        "lastUpdated": "2021-07-19T00:00:00.000Z",
        "nextSteps": "Phase IIa expected to be dosed July 2021… [+33]",
        "phase": "Phase I/II",
        "trimedCategory": "dna-based",
        "trimedName": "geneone-life-science"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; LNP-encapsulated mRNA (mRNA 1283)",
        "developerResearcher": "ModernaTX,\n  Inc.",
        "funder": "undefined",
        "lastUpdated": "2021-07-06T00:00:00.000Z",
        "nextSteps": "Phase I study of next generation COVID-1… [+48]",
        "phase": "Phase I",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "modernatx-inc."
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; LNP-encapsulated mRNA (mRNA 1273.35… [+2]",
        "developerResearcher": "Moderna/National Institute of Allergy an… [+29]",
        "funder": "undefined",
        "lastUpdated": "2021-07-06T00:00:00.000Z",
        "nextSteps": "Initial booster data announced May 2021;… [+25]",
        "phase": "Phase I",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "modernanational-institute-of-allergy-and-infectious-diseases-(niaid)"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "Lipid-Inorganic Nanoparticle (LION™) for… [+48]",
        "developerResearcher": "SENAI CIMATEC/ HDT Bio Corp",
        "funder": "undefined",
        "lastUpdated": "2021-07-06T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin July 2021",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "senai-cimatec-hdt-bio-corp"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Chimpanzee Adenovirus serotype 68 (chAd)… [+128]",
        "developerResearcher": "Gritstone Oncology, Inc.",
        "funder": "undefined",
        "lastUpdated": "2021-06-30T00:00:00.000Z",
        "nextSteps": "Phase I dosed March 2021",
        "phase": "Phase I",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "gritstone-oncology-inc."
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "CoV2-OGEN1, protein-based vaccine",
        "developerResearcher": "VaxForm",
        "funder": "undefined",
        "lastUpdated": "2021-06-30T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin June 2021",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "vaxform"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; LNP-encapsulated mRNA (mRNA 1273.21… [+2]",
        "developerResearcher": "ModernaTX,\n  Inc.",
        "funder": "undefined",
        "lastUpdated": "2021-06-30T00:00:00.000Z",
        "nextSteps": "Phase II/III began May 2021",
        "phase": "Phase II/III",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "modernatx-inc."
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated, Newcastle Disease Virus (ND… [+76]",
        "developerResearcher": "Government\n  Pharmaceutical Organization… [+33]",
        "funder": "undefined",
        "lastUpdated": "2021-06-30T00:00:00.000Z",
        "nextSteps": "Phase I/II began March 2021",
        "phase": "Phase I/II",
        "trimedCategory": "inactivated-virus",
        "trimedName": "government-pharmaceutical-organization-(gpo-thailand)-dynavax--path"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Intranasal Newcastle disease virus vecto… [+38]",
        "developerResearcher": "Farmacológicos Veterinarios SAC (FARVET … [+4]",
        "funder": "undefined",
        "lastUpdated": "2021-06-30T00:00:00.000Z",
        "nextSteps": "Pre-clinical results released March 2021… [+0]",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "farmacológicos-veterinarios-sac-(farvet-sac)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant SARS-CoV-2 Vaccine (CHO Cell… [+1]",
        "developerResearcher": "National Vaccine and Serum Institute, Ch… [+3]",
        "funder": "undefined",
        "lastUpdated": "2021-06-30T00:00:00.000Z",
        "nextSteps": "Phase I/II began recruiting April 2021",
        "phase": "Phase I/II",
        "trimedCategory": "protein-subunit",
        "trimedName": "national-vaccine-and-serum-institute-china"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated; (ERUCOV-VAC), (TURKOVAC)",
        "developerResearcher": "Erciyes University",
        "funder": "undefined",
        "lastUpdated": "2021-06-30T00:00:00.000Z",
        "nextSteps": "Phase III began June 2021; Phase II dose… [+76]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "erciyes-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; S protein (SpFN)",
        "developerResearcher": "Walter Reed Army Institute of Research (… [+59]",
        "funder": "undefined",
        "lastUpdated": "2021-06-30T00:00:00.000Z",
        "nextSteps": "Phase I began recruiting April 2021",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "walter-reed-army-institute-of-research-(wrair)-u.s.-army-medical-research-and-development-command"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Recombinant Newcastle disease virus (rND… [+14]",
        "developerResearcher": "Laboratorio Avi-Mex/ National Council of… [+106]",
        "funder": "undefined",
        "lastUpdated": "2021-06-30T00:00:00.000Z",
        "nextSteps": "Phase I began May 2021",
        "phase": "Phase I",
        "trimedCategory": "inactivated-virus",
        "trimedName": "laboratorio-avi-mex-national-council-of-science-and-technology-mexico-agencia-mexicana-de-cooperación-internacional-para-el-desarrollo-(amexid)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Intranasal Newcastle disease virus vecto… [+37]",
        "developerResearcher": "Farmacológicos\n  Veterinarios SAC (FARVE… [+6]",
        "funder": "undefined",
        "lastUpdated": "2021-06-30T00:00:00.000Z",
        "nextSteps": "Pre-clinical results released March 2021… [+0]",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "farmacológicos-veterinarios-sac-(farvet-sac)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant SARS-CoV-2 spike protein, al… [+30]",
        "developerResearcher": "Nanogen Pharmaceutical Biotechnology",
        "funder": "undefined",
        "lastUpdated": "2021-06-18T00:00:00.000Z",
        "nextSteps": "Phase III began June 2021; Phase II bega… [+44]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "nanogen-pharmaceutical-biotechnology"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP displaying the SARS-CoV-2 receptor-b… [+30]",
        "developerResearcher": "Icosavax",
        "funder": "undefined",
        "lastUpdated": "2021-06-11T00:00:00.000Z",
        "nextSteps": "Phase I/II began June 2021; Pre-clinical… [+31]",
        "phase": "Phase I/II",
        "trimedCategory": "virus-like-particle",
        "trimedName": "icosavax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Whole virion inactivated vaccine, CoviVa… [+1]",
        "developerResearcher": "Chumakov Federal Scientific Center for R… [+92]",
        "funder": "undefined",
        "lastUpdated": "2021-06-08T00:00:00.000Z",
        "nextSteps": "Phase III began March 2021; Russia \"regi… [+73]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "chumakov-federal-scientific-center-for-research-and-development-of-immune-and-biological-products-of-the-russian-academy-of-sciences"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "CIGB-66 (RBD + aluminum hydroxide)",
        "developerResearcher": "Center for Genetic Engineering and Biote… [+23]",
        "funder": "undefined",
        "lastUpdated": "2021-06-02T00:00:00.000Z",
        "nextSteps": "Cuba began rolling out the vaccine in a … [+127]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "center-for-genetic-engineering-and-biotechnology-(cigb)-havana"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD-based, (KBP-COVID-19)",
        "developerResearcher": "Kentucky BioProcessing (British American… [+9]",
        "funder": "undefined",
        "lastUpdated": "2021-05-31T00:00:00.000Z",
        "nextSteps": "Phase I/II began recruiting December 202… [+28]",
        "phase": "Phase I/II",
        "trimedCategory": "protein-subunit",
        "trimedName": "kentucky-bioprocessing-(british-american-tobacco)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated (inactivated + alum); (KD-41… [+2]",
        "developerResearcher": "KM Biologics",
        "funder": "undefined",
        "lastUpdated": "2021-05-31T00:00:00.000Z",
        "nextSteps": "Phase I/II study began March 2021",
        "phase": "Phase I/II",
        "trimedCategory": "inactivated-virus",
        "trimedName": "km-biologics"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (Covigenix)",
        "developerResearcher": "Entos Pharmaceuticals/ Cytiva",
        "funder": "Canadian Institutes of Health Research (… [+147]",
        "lastUpdated": "2021-05-31T00:00:00.000Z",
        "nextSteps": "Phase I/II began April 2021",
        "phase": "Phase I/II",
        "trimedCategory": "dna-based",
        "trimedName": "entos-pharmaceuticals-cytiva"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP; plant-derived VLP adjuvanted with G… [+32]",
        "developerResearcher": "Medicago Inc./ GlaxoSmithKline",
        "funder": "undefined",
        "lastUpdated": "2021-05-24T00:00:00.000Z",
        "nextSteps": "Phase II interim results released May 20… [+343]",
        "phase": "Phase II/III",
        "trimedCategory": "virus-like-particle",
        "trimedName": "medicago-inc.-glaxosmithkline"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "ABNCoV2 capsid virus-like particle, form… [+41]",
        "developerResearcher": "Radboud University",
        "funder": "undefined",
        "lastUpdated": "2021-04-30T00:00:00.000Z",
        "nextSteps": "Phase I of I/II study began March 2021",
        "phase": "Phase I",
        "trimedCategory": "virus-like-particle",
        "trimedName": "radboud-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "mRNA (ARCoV)",
        "developerResearcher": "People's Liberation Army (PLA) Academy o… [+35]",
        "funder": "undefined",
        "lastUpdated": "2021-04-30T00:00:00.000Z",
        "nextSteps": "Phase III expected to begin late May 202… [+151]",
        "phase": "Phase II",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "peoples-liberation-army-(pla)-academy-of-military-sciences-walvax-biotech"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant SARS-Cov-2 coronavirus fusio… [+25]",
        "developerResearcher": "Guangdong Provincial Center for Disease … [+73]",
        "funder": "undefined",
        "lastUpdated": "2021-04-30T00:00:00.000Z",
        "nextSteps": "Phase I began April 2021",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "guangdong-provincial-center-for-disease-control-and-prevention-gaozhou-center-for-disease-control-and-prevention"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Adneviral vector vaccine, (SC-Ad6-1)",
        "developerResearcher": "Tetherex Pharmaceuticals Corporation",
        "funder": "undefined",
        "lastUpdated": "2021-04-30T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin June 2021",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "tetherex-pharmaceuticals-corporation"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Adjuvanted recombinant protein (RBD-Dime… [+13]",
        "developerResearcher": "Anhui Zhifei Longcom Biopharmaceutical/ … [+54]",
        "funder": "undefined",
        "lastUpdated": "2021-04-30T00:00:00.000Z",
        "nextSteps": "China and Uzbekistan granted \"emergency … [+221]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "anhui-zhifei-longcom-biopharmaceutical-institute-of-microbiology-chinese-academy-of-sciences"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Adjuvanted inactivated vaccine",
        "developerResearcher": "Scientific and Technological Research Co… [+25]",
        "funder": "undefined",
        "lastUpdated": "2021-04-30T00:00:00.000Z",
        "nextSteps": "Phase I began end of April 2021",
        "phase": "Phase I",
        "trimedCategory": "inactivated-virus",
        "trimedName": "scientific-and-technological-research-council-of-turkey-(tubitak)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Egg-based, inactivated, whole chimeric N… [+141]",
        "developerResearcher": "Institute of Vaccines and Medical Biolog… [+38]",
        "funder": "undefined",
        "lastUpdated": "2021-04-28T00:00:00.000Z",
        "nextSteps": "Phase I/II began March 2021, Phase I is … [+43]",
        "phase": "Phase I/II",
        "trimedCategory": "inactivated-virus",
        "trimedName": "institute-of-vaccines-and-medical-biologicals-(ivac-vietnam)-dynavax--path"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP",
        "developerResearcher": "Scientific and Technological Research Co… [+79]",
        "funder": "undefined",
        "lastUpdated": "2021-04-28T00:00:00.000Z",
        "nextSteps": "Phase II expected to begin early June 20… [+35]",
        "phase": "Phase I",
        "trimedCategory": "virus-like-particle",
        "trimedName": "scientific-and-technological-research-council-of-turkey-(tübitak)-middle-east-technical-university-bilkent-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated, (QazCovid-in®)",
        "developerResearcher": "Research Institute for Biological Safety… [+33]",
        "funder": "undefined",
        "lastUpdated": "2021-04-28T00:00:00.000Z",
        "nextSteps": "Kazakhstan lauched nationwide vaccine ro… [+163]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "research-institute-for-biological-safety-problems-republic-of-kazakhstan"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "SARS-CoV-2-RBD-Fc fusion protein; (AKS-4… [+3]",
        "developerResearcher": "University Medical Center Groningen/ Aks… [+39]",
        "funder": "undefined",
        "lastUpdated": "2021-04-13T00:00:00.000Z",
        "nextSteps": "Phase I/II dosed April 2021",
        "phase": "Phase I/II",
        "trimedCategory": "protein-subunit",
        "trimedName": "university-medical-center-groningen-akston-biosciences-corporation-lakepharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector, intranasal flu… [+38]",
        "developerResearcher": "The University of Hong Kong/ Xiamen Univ… [+34]",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+2]",
        "lastUpdated": "2021-04-12T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin in Hong Kong i… [+104]",
        "phase": "Phase I/II",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "the-university-of-hong-kong-xiamen-university-wantai-biological-pharmacy"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Peptide vaccine, EpiVacCorona",
        "developerResearcher": "Federal Budgetary Research Institution (… [+66]",
        "funder": "undefined",
        "lastUpdated": "2021-03-29T00:00:00.000Z",
        "nextSteps": "Phase I/II interim results published Mar… [+133]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "federal-budgetary-research-institution-(fbri)-state-research-center-of-virology-and-biotechnology-\"vector\""
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "NDV-HXP-S vaccine, with or without the a… [+16]",
        "developerResearcher": "Mahidol University/ The Government Pharm… [+69]",
        "funder": "undefined",
        "lastUpdated": "2021-03-28T00:00:00.000Z",
        "nextSteps": "Phase I/II began March 2021",
        "phase": "Phase I/II",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "mahidol-university-the-government-pharmaceutical-organization-(gpo)-icahn-school-of-medicine-at-mount-sinai"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Adenovirus-based + HLA-matched peptides … [+12]",
        "developerResearcher": "Valo Therapeutics Ltd/ ImmunoScape",
        "funder": "undefined",
        "lastUpdated": "2021-03-28T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "valo-therapeutics-ltd-immunoscape"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Oral Ad5 S; (OraPro-Covid-19)",
        "developerResearcher": "iosBIO (formerly Stabilitech Biopharma L… [+3]",
        "funder": "undefined",
        "lastUpdated": "2021-03-28T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "iosbio-(formerly-stabilitech-biopharma-ltd)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "BBV154; adenovirus vectored, intranasal … [+7]",
        "developerResearcher": "Bharat Biotech International Limited",
        "funder": "undefined",
        "lastUpdated": "2021-03-28T00:00:00.000Z",
        "nextSteps": "Phase I began March 2021",
        "phase": "Phase I",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "bharat-biotech-international-limited"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Ad 5 vector for intranasal administratio… [+1]",
        "developerResearcher": "University of Helsinki/ University of Ea… [+46]",
        "funder": "undefined",
        "lastUpdated": "2021-03-28T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "university-of-helsinki-university-of-eastern-finland-rokote-laboratories-finland-ltd"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA (COVID-eVax)",
        "developerResearcher": "Takis/ Applied DNA Sciences/ Evvivax/ Ro… [+16]",
        "funder": "undefined",
        "lastUpdated": "2021-03-28T00:00:00.000Z",
        "nextSteps": "Phase I/II began March 2021, announced t… [+141]",
        "phase": "Phase I/II",
        "trimedCategory": "dna-based",
        "trimedName": "takis-applied-dna-sciences-evvivax-rottapharm-biotech"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "SARS-CoV-2 HLA-DR peptides, (CoVAC-1)",
        "developerResearcher": "University Hospital Tuebingen",
        "funder": "undefined",
        "lastUpdated": "2021-02-27T00:00:00.000Z",
        "nextSteps": "Phase I began December 2020",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "university-hospital-tuebingen"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, adjuvanted microsphere … [+28]",
        "developerResearcher": "VIDO-InterVac, University of Saskatchewa… [+1]",
        "funder": "The Government of Saskatchewan and the C… [+26]",
        "lastUpdated": "2021-02-27T00:00:00.000Z",
        "nextSteps": "Phase I/II dosed February 2021; Animal t… [+37]",
        "phase": "Phase I/II",
        "trimedCategory": "protein-subunit",
        "trimedName": "vido-intervac-university-of-saskatchewan"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "Myxoma virus co-expressing S, M, N and E… [+9]",
        "developerResearcher": "Arizona State University",
        "funder": "undefined",
        "lastUpdated": "2021-02-12T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "arizona-state-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "Plasmid driven production of virus like … [+64]",
        "developerResearcher": "Arizona State University",
        "funder": "undefined",
        "lastUpdated": "2021-02-12T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "arizona-state-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "Multiple mRNA vaccine candidates against… [+20]",
        "developerResearcher": "CureVac/UK Government (Vaccines Taskforc… [+2]",
        "funder": "undefined",
        "lastUpdated": "2021-02-05T00:00:00.000Z",
        "nextSteps": "Collaboration to develop and manufacture… [+115]",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "curevacuk-government-(vaccines-taskforce)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD (baculovirus production\nexpressed in… [+11]",
        "developerResearcher": "West China Hospital, Sichuan University",
        "funder": "undefined",
        "lastUpdated": "2021-02-04T00:00:00.000Z",
        "nextSteps": "Phase II began November 2020; Phase I be… [+61]",
        "phase": "Phase II",
        "trimedCategory": "protein-subunit",
        "trimedName": "west-china-hospital-sichuan-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "(CORVax12), IL-12 expression platform + … [+16]",
        "developerResearcher": "OncoSec Medical Incorporated / Providenc… [+18]",
        "funder": "undefined",
        "lastUpdated": "2021-02-02T00:00:00.000Z",
        "nextSteps": "Phase I dosed January 2021",
        "phase": "Phase I",
        "trimedCategory": "dna-based",
        "trimedName": "oncosec-medical-incorporated-providence-cancer-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "RBD SARS-CoV-2 HBsAg VLP vaccine",
        "developerResearcher": "Serum Institute of India/ Accelagen Pty/… [+11]",
        "funder": "undefined",
        "lastUpdated": "2021-01-31T00:00:00.000Z",
        "nextSteps": "Phase I of follow up Phase I/II clinical… [+84]",
        "phase": "Phase I/II",
        "trimedCategory": "virus-like-particle",
        "trimedName": "serum-institute-of-india-accelagen-pty-spybiotech"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated",
        "developerResearcher": "Institute of Medical Biology, Chinese Ac… [+25]",
        "funder": "undefined",
        "lastUpdated": "2021-01-31T00:00:00.000Z",
        "nextSteps": "Phase III dosed (Malaysia) late January … [+85]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "institute-of-medical-biology-chinese-academy-of-medical-sciences"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (AG0301 \u0026 AG0302) plasmid vaccine +… [+9]",
        "developerResearcher": "Osaka University/ AnGes/ Takara Bio/ Cyt… [+21]",
        "funder": "undefined",
        "lastUpdated": "2021-01-31T00:00:00.000Z",
        "nextSteps": "Phase II/III trial began December 2020; … [+152]",
        "phase": "Phase II/III",
        "trimedCategory": "dna-based",
        "trimedName": "osaka-university-anges-takara-bio-cytiva-brickell-biotech"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "CIGB-669 (RBD-AgnHB)",
        "developerResearcher": "Center for Genetic Engineering and Biote… [+23]",
        "funder": "undefined",
        "lastUpdated": "2021-01-31T00:00:00.000Z",
        "nextSteps": "Phase I of Phase I/II (MAMBISA) trial be… [+17]",
        "phase": "Phase I/II",
        "trimedCategory": "protein-subunit",
        "trimedName": "center-for-genetic-engineering-and-biotechnology-(cigb)-havana"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "LV-SMENP-DC vaccine and antigen-specific… [+5]",
        "developerResearcher": "Shenzhen Geno-Immune Medical Institute",
        "funder": "undefined",
        "lastUpdated": "2021-01-31T00:00:00.000Z",
        "nextSteps": "Phase I/II reportedly began March 2020",
        "phase": "Phase I/II",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "shenzhen-geno-immune-medical-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Covid-19/aAPC vaccine",
        "developerResearcher": "Shenzhen Geno-Immune Medical Institute",
        "funder": "undefined",
        "lastUpdated": "2021-01-31T00:00:00.000Z",
        "nextSteps": "Phase I reportedly began February 2020",
        "phase": "Phase I",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "shenzhen-geno-immune-medical-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; MVA encode… [+5]",
        "developerResearcher": "GeoVax / BravoVax/ NIAID/ NIH/ Universit… [+25]",
        "funder": "National Institute of Allergy and Infect… [+57]",
        "lastUpdated": "2021-01-25T00:00:00.000Z",
        "nextSteps": "Awarded a Small Business Innovative Rese… [+143]",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "geovax-bravovax-niaid-nih-university-of-texas-medical-branch"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating bacterial vector",
        "description": "Oral Salmonella enteritidis (3934Vac) ba… [+36]",
        "developerResearcher": "Farmacológicos Veterinarios SAC (FARVET … [+4]",
        "funder": "undefined",
        "lastUpdated": "2021-01-19T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-bacterial-vector",
        "trimedName": "farmacológicos-veterinarios-sac-(farvet-sac)"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "3 LNP-mRNAs; BNT162 \n",
        "developerResearcher": "BioNTech/ Pfizer/ Fosun Pharma/ Rentschl… [+12]",
        "funder": "undefined",
        "lastUpdated": "2020-12-18T00:00:00.000Z",
        "nextSteps": "U.S. FDA issued \"emergency use authoriza… [+1187]",
        "phase": "Authorized",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "biontech-pfizer-fosun-pharma-rentschler-biopharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; LNP-encapsulated mRNA (mRNA 1273)",
        "developerResearcher": "Moderna/ NIAID/ Lonza/ Catalent/ Rovi/ M… [+16]",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+66]",
        "lastUpdated": "2020-12-18T00:00:00.000Z",
        "nextSteps": "U.S. FDA issued \"emergency use authoriza… [+1078]",
        "phase": "Authorized",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "moderna-niaid-lonza-catalent-rovi-medidata-bioqual"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated; whole-virion (COVAXIN) (BBV… [+4]",
        "developerResearcher": "Bharat Biotech/ Indian Council of Medica… [+42]",
        "funder": "undefined",
        "lastUpdated": "2020-12-01T00:00:00.000Z",
        "nextSteps": "Phase III dosed November 2020; Phase I/I… [+153]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "bharat-biotech-indian-council-of-medical-research-national-institute-of-virology"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; LNP-encapsulated mRNA (mRNA 1273)",
        "developerResearcher": "Moderna/ NIAID/ Lonza/ Catalent/ Rovi/ M… [+16]",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+66]",
        "lastUpdated": "2020-11-30T00:00:00.000Z",
        "nextSteps": "Submitted Emergency Use Authorization (E… [+872]",
        "phase": "Regulatory Review",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "moderna-niaid-lonza-catalent-rovi-medidata-bioqual"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "MVA-based SARS-CoV-2 vaccine; (COH04S1)",
        "developerResearcher": "City of\n  Hope Medical Center",
        "funder": "undefined",
        "lastUpdated": "2020-11-24T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin November 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "city-of-hope-medical-center"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated (inactivated + alum); Corona… [+23]",
        "developerResearcher": "Sinovac/ Instituto Butantan/ Bio Farma",
        "funder": "undefined",
        "lastUpdated": "2020-11-24T00:00:00.000Z",
        "nextSteps": "Phase III trial interim results expected… [+549]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "sinovac-instituto-butantan-bio-farma"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Adeno-based, Gam-COVID-Vac Lyo (Sputnik … [+2]",
        "developerResearcher": "Gamaleya Research Institute",
        "funder": "Russian Direct Investment Fund (RDIF)",
        "lastUpdated": "2020-11-24T00:00:00.000Z",
        "nextSteps": "Phase III trial interim data analysis re… [+255]",
        "phase": "Phase III",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "gamaleya-research-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; AZD 1222 (… [+17]",
        "developerResearcher": "University of Oxford, Oxford Biomedica, … [+187]",
        "funder": "Coalition for Epidemic Preparedness Inno… [+121]",
        "lastUpdated": "2020-11-23T00:00:00.000Z",
        "nextSteps": "Phase II/III (COV002) and Phase III (COV… [+640]",
        "phase": "Phase III",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "university-of-oxford-oxford-biomedica,-vaccines-manufacturing-and-innovation-centre,-pall-life-sciences,-cobra-biologics,-halixbv,-advent-s.r.l.,-merck-kgaa,-the-serum-institute,-vaccitech,-catalent,-csl,-and-astrazenecaiqvia"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "3 LNP-mRNAs; BNT162 \n",
        "developerResearcher": "BioNTech/ Pfizer/ Fosun Pharma/ Rentschl… [+12]",
        "funder": "undefined",
        "lastUpdated": "2020-11-23T00:00:00.000Z",
        "nextSteps": "Submitted Emergency Use Authorization (E… [+782]",
        "phase": "Regulatory Review",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "biontech-pfizer-fosun-pharma-rentschler-biopharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "(CORVax12), IL-12 expression platform + … [+16]",
        "developerResearcher": "OncoSec Medical Incorporated / Providenc… [+18]",
        "funder": "undefined",
        "lastUpdated": "2020-11-18T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin December 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "oncosec-medical-incorporated-providence-cancer-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP displaying the SARS-CoV-2 receptor-b… [+30]",
        "developerResearcher": "Icosavax",
        "funder": "undefined",
        "lastUpdated": "2020-11-18T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin mid-2021; Pre-… [+39]",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "icosavax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, recombinant S protein i… [+9]",
        "developerResearcher": "Vabiotech",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "vabiotech"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; Adenovirus… [+25]",
        "developerResearcher": "CanSino Biologics/ Beijing Institute of … [+23]",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase III dosed September 2020; Phase II… [+154]",
        "phase": "Phase III",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "cansino-biologics-beijing-institute-of-biotechnology-petrovax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "rRBD produced in CHO-cell chemically con… [+24]",
        "developerResearcher": "Instituto Finlay de Vacunas",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin November 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "instituto-finlay-de-vacunas"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (CoVAXIX) plasmid vaccine",
        "developerResearcher": "Statens Serum Institute, Denmark",
        "funder": "Folketing's Finance Committee",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase I is expected to start in late 202… [+15]",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "statens-serum-institute-denmark"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "saRNA formulated in a NLC",
        "developerResearcher": "Infectious Disease Research Institute/ A… [+11]",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin mid-2021",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "infectious-disease-research-institute-amyris-inc."
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (Covigenix)",
        "developerResearcher": "Entos Pharmaceuticals/ Cytiva",
        "funder": "Canadian Institutes of Health Research (… [+60]",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase I/II expected to begin November 20… [+2]",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "entos-pharmaceuticals-cytiva"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Peptides",
        "developerResearcher": "Neo7Logix",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "neo7logix"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; DPX-COVID-19, protein s… [+42]",
        "developerResearcher": "IMV, Inc., Canadian Center for Vaccinolo… [+215]",
        "funder": "National Research Council of Canada Indu… [+139]",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase I/II expected to begin by end of 2… [+3]",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "imv-inc.,-canadian-center-for-vaccinology-at-dalhousie-university,-izaak-walton-killam-health-center,-nova-scotia-health-authority,-canadian-immunization-research-network,-university-of-laval,-global-urgent-and-advanced-research-and-development-in-canada"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (GX-19)",
        "developerResearcher": "Genexine Consortium (GenNBio, Internatio… [+160]",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase I/II study: Phase I began end of J… [+52]",
        "phase": "Phase I/II",
        "trimedCategory": "dna-based",
        "trimedName": "genexine-consortium-(gennbio-international-vaccine-institute,-korea-advanced-institute-of-science-and-technology-(kaist),-pohang-university-of-science-and-technology-(postech)-binex-pt-kalbe-pharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit",
        "developerResearcher": "MOGAM Institute for Biomedical Research,… [+10]",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "mogam-institute-for-biomedical-research-gc-pharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Ad26.COV2-S, Non replicating viral vecto… [+33]",
        "developerResearcher": "Janssen Pharmaceutical Companies/ Beth I… [+119]",
        "funder": "Biomedical Advanced Research and Develop… [+22]",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase III trial to study the safety and … [+566]",
        "phase": "Phase III",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "janssen-pharmaceutical-companies-beth-israel-deaconess-medical-center-emergent-biosolutions-catalent-biological-e-grand-river-aseptic-manufacturing-(gram)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, capsid-like particle (C… [+3]",
        "developerResearcher": "AdaptVac (PREVENT-nCoV consortium)",
        "funder": "European Commission (Horizon 2020 Progra… [+2]",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "adaptvac-(prevent-ncov-consortium)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated; (ERUCOV-VAC)",
        "developerResearcher": "Erciyes University",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase I began November 2020",
        "phase": "Phase I",
        "trimedCategory": "inactivated-virus",
        "trimedName": "erciyes-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "LNP-mRNA; (ChulaCov19)",
        "developerResearcher": "Chula Vaccine Research Center/University… [+16]",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin January 2021",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "chula-vaccine-research-centeruniversity-of-pennsylvania"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (AG0301 \u0026 AG0302) plasmid vaccine +… [+9]",
        "developerResearcher": "Osaka University/ AnGes/ Takara Bio/ Cyt… [+21]",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Pre-clinical study results released Octo… [+112]",
        "phase": "Phase I/II",
        "trimedCategory": "dna-based",
        "trimedName": "osaka-university-anges-takara-bio-cytiva-brickell-biotech"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; Full-length recombinant… [+84]",
        "developerResearcher": "Novavax/Emergent Biosolutions/ Praha Vac… [+175]",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+46]",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "FDA granted Fast Track Designation on 11… [+427]",
        "phase": "Phase III",
        "trimedCategory": "protein-subunit",
        "trimedName": "novavaxemergent-biosolutions-praha-vaccines-biofabri-fujifilm-diosynth-biotechnologies-fdb-serum-institute-of-india-sk-bioscience-takeda-pharmaceutical-company-limited-agc-biologics-polypeptide-group-endo"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; S protein (SpFN)",
        "developerResearcher": "WRAIR / USAMRIID",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin late 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "wrair-usamriid"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (COVIGEN) needle-free delivery",
        "developerResearcher": "BioNet Asia/ Technovalia/ Vax4COVID/ The… [+94]",
        "funder": "Australian Government Medical Research F… [+17]",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin Q4 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "bionet-asia-technovalia-vax4covid-the-university-of-sydney-the-university-of-western-australia-telethon-kids-institute-pharmajet"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Peptides derived from Spike protein; (AC… [+5]",
        "developerResearcher": "Axon Neuroscience SE",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "Pre-clinical results released September … [+4]",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "axon-neuroscience-se"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Recombinant deactivated rabies virus con… [+21]",
        "developerResearcher": "Bharat Biotech/ Thomas Jefferson Univers… [+3]",
        "funder": "undefined",
        "lastUpdated": "2020-11-16T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "bharat-biotech-thomas-jefferson-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant spike protein with Essai O/W… [+17]",
        "developerResearcher": "Kazakh National Agrarian University, Kaz… [+71]",
        "funder": "undefined",
        "lastUpdated": "2020-11-10T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "kazakh-national-agrarian-university-kazakhstan-national-scientific-center-for-especially-dangerous-infections"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant S protein",
        "developerResearcher": "Max-Planck Institute of Colloids and Int… [+7]",
        "funder": "KHAN-1 Technology Transfer Fund I GmbH \u0026… [+6]",
        "lastUpdated": "2020-11-10T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "max-planck-institute-of-colloids-and-interfaces"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant S protein produced in BEVS",
        "developerResearcher": "Tampere University",
        "funder": "undefined",
        "lastUpdated": "2020-11-10T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "tampere-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant spike protein with Essai O/W… [+17]",
        "developerResearcher": "Kazakh National Agrarian University",
        "funder": "undefined",
        "lastUpdated": "2020-11-10T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "kazakh-national-agrarian-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; [E1-, E2b-… [+38]",
        "developerResearcher": "ImmunityBio/ NantKwest",
        "funder": "undefined",
        "lastUpdated": "2020-11-10T00:00:00.000Z",
        "nextSteps": "Phase I interim data announced November … [+167]",
        "phase": "Phase I",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "immunitybio-nantkwest"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD protein delivered in mannose-conjuga… [+25]",
        "developerResearcher": "Ohio State University/ Kazakh National A… [+18]",
        "funder": "undefined",
        "lastUpdated": "2020-11-10T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "ohio-state-university-kazakh-national-agrarian-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLPs produced in BEVS",
        "developerResearcher": "Tampere University",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "tampere-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP",
        "developerResearcher": "Max-Planck Institute for Dynamics of Com… [+22]",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "max-planck-institute-for-dynamics-of-complex-technical-systems"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA plasmid vaccine",
        "developerResearcher": "Globe Biotech Limited, Bangladesh",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "globe-biotech-limited-bangladesh"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Adenovirus Type 5 Vector",
        "developerResearcher": "Globe Biotech Limited, Bangladesh",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "globe-biotech-limited-bangladesh"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Egg-based, inactivated, whole chimeric N… [+130]",
        "developerResearcher": "Institute of Vaccines and Medical Biolog… [+38]",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "institute-of-vaccines-and-medical-biologicals-(ivac-vietnam)-dynavax--path"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Ad 5 vector for intranasal administratio… [+1]",
        "developerResearcher": "University of Helsinki/ University of Ea… [+13]",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "university-of-helsinki-university-of-eastern-finland"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "Plasmid DNA, nanostructured RBD",
        "developerResearcher": "National Institute of Chemistry, Sloveni… [+1]",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "national-institute-of-chemistry-slovenia"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating VSV vector-based DC-targetin… [+1]",
        "developerResearcher": "University of Manitoba",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "university-of-manitoba"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "T cell-based vaccine platform (CoVepiT)",
        "developerResearcher": "OSE\n  Immunotherapeutics",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "Clinical\n  trials expected to begin end … [+66]",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "ose-immunotherapeutics"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "D614G variant LNP-encapsulated mRNA",
        "developerResearcher": "Globe Biotech Limited, Bangladesh",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "globe-biotech-limited-bangladesh"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "LNP-encapsulated mRNA encoding S",
        "developerResearcher": "Max-Planck Institute of Colloids and Int… [+7]",
        "funder": "KHAN-1 Technology Transfer Fund I GmbH \u0026… [+6]",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "max-planck-institute-of-colloids-and-interfaces"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Intranasal Newcastle disease virus vecto… [+30]",
        "developerResearcher": "Farmacológicos Veterinarios SAC (FARVET … [+49]",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "farmacológicos-veterinarios-sac-(farvet-sac)-universidad-peruana-cayetano-heredia-(upch)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "Virus-like particle-based dendritic cell… [+18]",
        "developerResearcher": "University of Manitoba",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "university-of-manitoba"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated",
        "developerResearcher": "Kocak Farma Ilac ve Kimya San. A.S.",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "kocak-farma-ilac-ve-kimya-san.-a.s."
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Egg-based, inactivated, whole chimeric N… [+130]",
        "developerResearcher": "Government\n  Pharmaceutical Organization… [+33]",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "government-pharmaceutical-organization-(gpo-thailand)-dynavax--path"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Egg-based, inactivated, whole chimeric N… [+130]",
        "developerResearcher": "Institute\n  Butantan (Brazil) / Dynavax … [+6]",
        "funder": "undefined",
        "lastUpdated": "2020-11-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "institute-butantan-(brazil)-dynavax--path"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD + Adjuvant (FINLAY-FR-1)",
        "developerResearcher": "Instituto Finlay de Vacunas",
        "funder": "undefined",
        "lastUpdated": "2020-11-03T00:00:00.000Z",
        "nextSteps": "Phase I/II began August 2020",
        "phase": "Phase I/II",
        "trimedCategory": "protein-subunit",
        "trimedName": "instituto-finlay-de-vacunas"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "Enveloped virus-like particle (eVLP): Pa… [+93]",
        "developerResearcher": "VBI Vaccines / National Research Council… [+38]",
        "funder": "undefined",
        "lastUpdated": "2020-11-03T00:00:00.000Z",
        "nextSteps": "Phase I/II trial expected to begin by en… [+9]",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "vbi-vaccines-national-research-council-of-canada-therapure-biomanufacturing"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated",
        "developerResearcher": "Beijing Minhai Biotechnology Co., Ltd.",
        "funder": "undefined",
        "lastUpdated": "2020-11-03T00:00:00.000Z",
        "nextSteps": "Phase II expected to begin recruiting en… [+74]",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "beijing-minhai-biotechnology-co.-ltd."
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "S1-RBD-protein; Multitope Peptide-Based … [+21]",
        "developerResearcher": "Covaxx/ University of Nebraska Medical C… [+47]",
        "funder": "Ministry of Health and Welfare in Taiwan… [+0]",
        "lastUpdated": "2020-11-03T00:00:00.000Z",
        "nextSteps": "Phase I began September 2020; Large scal… [+78]",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "covaxx-university-of-nebraska-medical-center-(unmc)-dasa-united-biomedical-inc.-asia"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, native like trimeric su… [+19]",
        "developerResearcher": "Clover Biopharmaceuticals Inc./ GSK/ Dyn… [+4]",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+2]",
        "lastUpdated": "2020-11-03T00:00:00.000Z",
        "nextSteps": "Pre-clinical results released September … [+192]",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "clover-biopharmaceuticals-inc.-gsk-dynavax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "VSV-S",
        "developerResearcher": "Israel\n  Institute for Biological Resear… [+33]",
        "funder": "undefined",
        "lastUpdated": "2020-11-03T00:00:00.000Z",
        "nextSteps": "Phase I/II expected to begin recruiting … [+19]",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "israel-institute-for-biological-research-weizmann-institute-of-science"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP; plant-derived VLP adjuvanted with G… [+19]",
        "developerResearcher": "Medicago Inc.",
        "funder": "undefined",
        "lastUpdated": "2020-11-02T00:00:00.000Z",
        "nextSteps": "Phase II expected to begin in early Nove… [+80]",
        "phase": "Phase I",
        "trimedCategory": "virus-like-particle",
        "trimedName": "medicago-inc."
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; mRNA (CVnCoV)",
        "developerResearcher": "CureVac",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+201]",
        "lastUpdated": "2020-11-02T00:00:00.000Z",
        "nextSteps": "Phase IIb/III trial expected to begin by… [+173]",
        "phase": "Phase II",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "curevac"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Ad5-nCoV",
        "developerResearcher": "CanSino Biologics/ Institute of Biotechn… [+57]",
        "funder": "undefined",
        "lastUpdated": "2020-11-02T00:00:00.000Z",
        "nextSteps": "Phase I recruitment began end of Septemb… [+7]",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "cansino-biologics-institute-of-biotechnology-academy-of-military-medical-sciences,-pla-of-china"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; bacTRL-Spike",
        "developerResearcher": "Symvivo",
        "funder": "National Research Council of Canada Indu… [+45]",
        "lastUpdated": "2020-11-02T00:00:00.000Z",
        "nextSteps": "Phase I dosed November 2020",
        "phase": "Phase I",
        "trimedCategory": "dna-based",
        "trimedName": "symvivo"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (DIOS-CoVax2) synthetic gene insert… [+43]",
        "developerResearcher": "University of Cambridge/ DIOSynVax/ Phar… [+5]",
        "funder": "Innovate UK",
        "lastUpdated": "2020-10-28T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin late fall 2020… [+14]",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "university-of-cambridge-diosynvax-pharmajet"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector, replication-co… [+106]",
        "developerResearcher": "IAVI/ Merck",
        "funder": "Biomedical Advanced Research and Develop… [+102]",
        "lastUpdated": "2020-10-28T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin in late Octobe… [+93]",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "iavi-merck"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "MVC-COV1901 vaccine injection; S-2 P pro… [+15]",
        "developerResearcher": "Medigen Vaccine Biologics Corp/ NIAID/ D… [+6]",
        "funder": "undefined",
        "lastUpdated": "2020-10-20T00:00:00.000Z",
        "nextSteps": "Phase I dosed in early October 2020; Rec… [+136]",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "medigen-vaccine-biologics-corp-niaid-dynavax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated",
        "developerResearcher": "Wuhan Institute of Biological Products/ … [+9]",
        "funder": "undefined",
        "lastUpdated": "2020-10-20T00:00:00.000Z",
        "nextSteps": "Phase III trial began July 2020; Phase I… [+179]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "wuhan-institute-of-biological-products-sinopharm"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated, (BBIBP-CorV)",
        "developerResearcher": "Beijing Institute of Biological Products… [+11]",
        "funder": "undefined",
        "lastUpdated": "2020-10-20T00:00:00.000Z",
        "nextSteps": "Phase I/II results published October 202… [+120]",
        "phase": "Phase III",
        "trimedCategory": "inactivated-virus",
        "trimedName": "beijing-institute-of-biological-products-sinopharm"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; MVA-S enco… [+3]",
        "developerResearcher": "German Center for Infection Research (DZ… [+148]",
        "funder": "undefined",
        "lastUpdated": "2020-10-20T00:00:00.000Z",
        "nextSteps": "Phase I expected to be dosed mid-October… [+5]",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "german-center-for-infection-research-(dzif)-idt-biologika-gmbh-universitätsklinikum-hamburg-eppendorf-philipps-university-marburg-medical-center-ludwig-maximilians-university-of-munich"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Peptide vaccine, EpiVacCorona",
        "developerResearcher": "Federal Budgetary Research Institution (… [+66]",
        "funder": "undefined",
        "lastUpdated": "2020-10-15T00:00:00.000Z",
        "nextSteps": "Received early approval for use in Russi… [+58]",
        "phase": "Phase I/II",
        "trimedCategory": "protein-subunit",
        "trimedName": "federal-budgetary-research-institution-(fbri)-state-research-center-of-virology-and-biotechnology-\"vector\""
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "LNP-mRNA\n",
        "developerResearcher": "Sanofi Pasteur / Translate Bio",
        "funder": "undefined",
        "lastUpdated": "2020-10-15T00:00:00.000Z",
        "nextSteps": "Phase I/II to start Q4 2020; Pre-clinica… [+31]",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "sanofi-pasteur-translate-bio"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; Oral Vacci… [+12]",
        "developerResearcher": "Vaxart/ Emergent BioSolutions",
        "funder": "undefined",
        "lastUpdated": "2020-10-13T00:00:00.000Z",
        "nextSteps": "Phase I dosed October 2020; FDA clearanc… [+201]",
        "phase": "Phase I",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "vaxart-emergent-biosolutions"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated",
        "developerResearcher": "Institute of Medical Biology, Chinese Ac… [+25]",
        "funder": "undefined",
        "lastUpdated": "2020-10-09T00:00:00.000Z",
        "nextSteps": "Phase II began June 2020; Phase I began … [+39]",
        "phase": "Phase II",
        "trimedCategory": "inactivated-virus",
        "trimedName": "institute-of-medical-biology-chinese-academy-of-medical-sciences"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; recombinant spike prote… [+33]",
        "developerResearcher": "Vaxine Pty Ltd/ Flinders University/ Ora… [+54]",
        "funder": "Innovate UK/ Australian Government",
        "lastUpdated": "2020-10-01T00:00:00.000Z",
        "nextSteps": "Phase I trial began July 2020",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "vaxine-pty-ltd-flinders-university-oracle-medytox-sypharma-oxford-expression-technologies"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD-based, (KBP-COVID-19)",
        "developerResearcher": "Kentucky BioProcessing (British American… [+9]",
        "funder": "undefined",
        "lastUpdated": "2020-09-28T00:00:00.000Z",
        "nextSteps": "Phase I/II expected to begin mid-Novembe… [+6]",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "kentucky-bioprocessing-(british-american-tobacco)"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (INO-4800) plasmid vaccine with ele… [+12]",
        "developerResearcher": "Inovio Pharmaceuticals/ Beijing Advaccin… [+164]",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+48]",
        "lastUpdated": "2020-09-28T00:00:00.000Z",
        "nextSteps": "FDA partial clinical hold for planned Ph… [+236]",
        "phase": "Phase I/II",
        "trimedCategory": "dna-based",
        "trimedName": "inovio-pharmaceuticals-beijing-advaccine-biotechnology-vgxi-inc.-richter-helm-biologics-ology-bioservices-international-vaccine-institute-seoul-national-university-hospital-thermo-fisher-scientific"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "TerraCoV2\n",
        "developerResearcher": "Oragenics (Noachis Terra)/ Aragen Biosci… [+5]",
        "funder": "undefined",
        "lastUpdated": "2020-09-28T00:00:00.000Z",
        "nextSteps": "Phase I expected to start in early 2021",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "oragenics-(noachis-terra)-aragen-bioscience-"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; molecular clamp stabili… [+36]",
        "developerResearcher": "University of Queensland/CSL/Seqirus",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+78]",
        "lastUpdated": "2020-09-28T00:00:00.000Z",
        "nextSteps": "Phase I trial began July 2020",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "university-of-queenslandcslseqirus"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector, intranasal flu… [+38]",
        "developerResearcher": "The University of Hong Kong/ Xiamen Univ… [+34]",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+2]",
        "lastUpdated": "2020-09-28T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin in Hong Kong i… [+63]",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "the-university-of-hong-kong-xiamen-university-wantai-biological-pharmacy"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "Hepatitis B surface antigen (HBsAg) VLPs… [+0]",
        "developerResearcher": "SpyBiotech/\n  Serum Institute of India",
        "funder": "undefined",
        "lastUpdated": "2020-09-28T00:00:00.000Z",
        "nextSteps": "Phase I/II began September 2020",
        "phase": "Phase I/II",
        "trimedCategory": "virus-like-particle",
        "trimedName": "spybiotech-serum-institute-of-india"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Adjuvanted recombinant protein (RBD-Dime… [+2]",
        "developerResearcher": "Anhui Zhifei Longcom Biopharmaceutical/ … [+54]",
        "funder": "undefined",
        "lastUpdated": "2020-09-28T00:00:00.000Z",
        "nextSteps": "Phase II began July 2020; Received appro… [+107]",
        "phase": "Phase II",
        "trimedCategory": "protein-subunit",
        "trimedName": "anhui-zhifei-longcom-biopharmaceutical-institute-of-microbiology-chinese-academy-of-sciences"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; plasmid vaccine RBD\u0026N",
        "developerResearcher": "Scancell/ University of Nottingham/ Nott… [+23]",
        "funder": "undefined",
        "lastUpdated": "2020-09-23T00:00:00.000Z",
        "nextSteps": "Phase I to start in Q1 2021",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "scancell-university-of-nottingham-nottingham-trent-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA",
        "developerResearcher": "Ege University Drug Development and Phar… [+116]",
        "funder": "undefined",
        "lastUpdated": "2020-09-23T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "ege-university-drug-development-and-pharmacokinetic-research-application-center-(argefar)-scientific-and-technological-research-council-of-turkey-(tubitak)"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA with electroporation",
        "developerResearcher": "Chula Vaccine Research Center",
        "funder": "undefined",
        "lastUpdated": "2020-09-23T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "chula-vaccine-research-center"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated",
        "developerResearcher": "Selcuk University",
        "funder": "undefined",
        "lastUpdated": "2020-09-23T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "selcuk-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA with electroporation",
        "developerResearcher": "OPENCORONA Project: Karolinska Institute… [+133]",
        "funder": "European Commission (Horizon 2020 Progra… [+2]",
        "lastUpdated": "2020-09-23T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin in 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "opencorona-project:-karolinska-institute-justus-liebig-university-giessen-public-health-agency-of-sweden-(fohm)-igea-cobra-biologics-adlego-biomedical-region-stockholm"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; (ZyCoV-D) plasmid vaccine",
        "developerResearcher": "Zydus Cadila Healthcare Limited",
        "funder": "undefined",
        "lastUpdated": "2020-09-23T00:00:00.000Z",
        "nextSteps": "Phase I/II study: Phase I began July 202… [+73]",
        "phase": "Phase I/II",
        "trimedCategory": "dna-based",
        "trimedName": "zydus-cadila-healthcare-limited"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; msDNA-VLP",
        "developerResearcher": "Mediphage Bioceuticals/ University of Wa… [+23]",
        "funder": "undefined",
        "lastUpdated": "2020-09-23T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "mediphage-bioceuticals-university-of-waterloo-lambton-college"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA",
        "developerResearcher": "Takis/ Applied DNA Sciences/ Evvivax",
        "funder": "undefined",
        "lastUpdated": "2020-09-23T00:00:00.000Z",
        "nextSteps": "Pre-clinical results released in May and… [+47]",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "takis-applied-dna-sciences-evvivax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; S protein, baculovirus … [+10]",
        "developerResearcher": "Sanofi Pasteur/ GSK",
        "funder": "Biomedical Advanced Research and Develop… [+104]",
        "lastUpdated": "2020-09-22T00:00:00.000Z",
        "nextSteps": "Phase I/II began September 2020; Selecte… [+76]",
        "phase": "Phase I/II",
        "trimedCategory": "protein-subunit",
        "trimedName": "sanofi-pasteur-gsk"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "SARS-CoV-2 HLA-DR peptides",
        "developerResearcher": "University Hospital Tuebingen",
        "funder": "undefined",
        "lastUpdated": "2020-09-18T00:00:00.000Z",
        "nextSteps": "Phase I expected to begin September 2020… [+0]",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "university-hospital-tuebingen"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated, QAZCOVID-IN®",
        "developerResearcher": "Research Institute for Biological Safety… [+33]",
        "funder": "undefined",
        "lastUpdated": "2020-09-17T00:00:00.000Z",
        "nextSteps": "Phase I/II began September 2020",
        "phase": "Phase I/II",
        "trimedCategory": "inactivated-virus",
        "trimedName": "research-institute-for-biological-safety-problems-republic-of-kazakhstan"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector; measles vector… [+27]",
        "developerResearcher": "Institut Pasteur/ Themis/ University of … [+35]",
        "funder": "Coalition for Epidemic Preparedness (CEP… [+2]",
        "lastUpdated": "2020-09-17T00:00:00.000Z",
        "nextSteps": "Phase I/II began September 2020; Animal … [+24]",
        "phase": "Phase I/II",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "institut-pasteur-themis-university-of-pittsburgh-cvr-merck-sharp-\u0026-dohme"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "LUNAR-COV19; RNA; mRNA",
        "developerResearcher": "Arcturus/Duke-NUS/ Catalent\n",
        "funder": "undefined",
        "lastUpdated": "2020-09-10T00:00:00.000Z",
        "nextSteps": "Pre-clinical results released September … [+109]",
        "phase": "Phase I/II",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "arcturusduke-nus-catalent-"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD (baculovirus production\nexpressed in… [+11]",
        "developerResearcher": "West China Hospital, Sichuan University",
        "funder": "undefined",
        "lastUpdated": "2020-09-10T00:00:00.000Z",
        "nextSteps": "Phase I began end of August 2020; Animal… [+31]",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "west-china-hospital-sichuan-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; LNP-nCoVsaRNA",
        "developerResearcher": "Imperial College London/ VacEquity Globa… [+8]",
        "funder": "UK Government",
        "lastUpdated": "2020-09-10T00:00:00.000Z",
        "nextSteps": "Pre-clinical results published July 2020… [+34]",
        "phase": "Phase I/II",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "imperial-college-london-vacequity-global-health"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Intranasal lentiviral vector vaccine",
        "developerResearcher": "Institut\n  Pasteur/ TheraVectys",
        "funder": "undefined",
        "lastUpdated": "2020-09-02T00:00:00.000Z",
        "nextSteps": "Animal study results released July 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "institut-pasteur-theravectys"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Baculovirus-insect cells expression syst… [+35]",
        "developerResearcher": "Adimmune\n  Corporation",
        "funder": "undefined",
        "lastUpdated": "2020-09-02T00:00:00.000Z",
        "nextSteps": "Phase I began end of August 2020; Phase … [+34]",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "adimmune-corporation"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "undefined",
        "developerResearcher": "United\n  Biomedical (UBI)/ c19",
        "funder": "undefined",
        "lastUpdated": "2020-09-02T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "united-biomedical-(ubi)-c19"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "srRNA (EXG-5003)",
        "developerResearcher": "Elixirgen Therapeutics/ Fujita Health Un… [+8]",
        "funder": "Japan Agency for Medical Research and De… [+16]",
        "lastUpdated": "2020-09-01T00:00:00.000Z",
        "nextSteps": "Clinical trials are expected to begin at… [+61]",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "elixirgen-therapeutics-fujita-health-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector; measles vector… [+0]",
        "developerResearcher": "Federal Budgetary Research Institution (… [+66]",
        "funder": "undefined",
        "lastUpdated": "2020-08-31T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "federal-budgetary-research-institution-(fbri)-state-research-center-of-virology-and-biotechnology-\"vector\""
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; replicatio… [+63]",
        "developerResearcher": "ReiThera/ Leukocare/ Univercells/ Nation… [+55]",
        "funder": "undefined",
        "lastUpdated": "2020-08-31T00:00:00.000Z",
        "nextSteps": "Phase I began August 2020; Phase II/III … [+42]",
        "phase": "Phase I",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "reithera-leukocare-univercells-national-institute-of-infectious-diseases-lazzaro-spallanzani"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Subunit vaccine",
        "developerResearcher": "Federal Budgetary Research Institution (… [+66]",
        "funder": "undefined",
        "lastUpdated": "2020-08-31T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "federal-budgetary-research-institution-(fbri)-state-research-center-of-virology-and-biotechnology-\"vector\""
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant SARS-CoV-2 Spike Protein Vac… [+27]",
        "developerResearcher": "Shanghai\n  Zerun Biotechnology Co., Ltd/… [+30]",
        "funder": "Coalition for Epidemic Prepardeness (CEP… [+2]",
        "lastUpdated": "2020-08-31T00:00:00.000Z",
        "nextSteps": "Phase I began July 2021",
        "phase": "Phase I",
        "trimedCategory": "protein-subunit",
        "trimedName": "shanghai-zerun-biotechnology-co.-ltd-walvax-biotechnology-co.,-ltd"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; mRNA (DS-5670)",
        "developerResearcher": "Daiichi-Sankyo/ University of Tokyo's In… [+26]",
        "funder": "undefined",
        "lastUpdated": "2020-08-31T00:00:00.000Z",
        "nextSteps": "Clinical studies expected to begin March… [+5]",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "daiichi-sankyo-university-of-tokyos-institute-of-medical-science"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; mRNA",
        "developerResearcher": "Federal Budgetary Research Institution (… [+66]",
        "funder": "undefined",
        "lastUpdated": "2020-08-31T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "federal-budgetary-research-institution-(fbri)-state-research-center-of-virology-and-biotechnology-\"vector\""
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector; VSV vector",
        "developerResearcher": "Federal Budgetary Research Institution (… [+66]",
        "funder": "undefined",
        "lastUpdated": "2020-08-31T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "federal-budgetary-research-institution-(fbri)-state-research-center-of-virology-and-biotechnology-\"vector\""
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector, recombinant va… [+77]",
        "developerResearcher": "Federal Budgetary Research Institution (… [+66]",
        "funder": "undefined",
        "lastUpdated": "2020-08-31T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "federal-budgetary-research-institution-(fbri)-state-research-center-of-virology-and-biotechnology-\"vector\""
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating bacterial vector",
        "description": "Oral Salmonella enteritidis (3934Vac) ba… [+36]",
        "developerResearcher": "Farmacológicos Veterinarios SAC (FARVET … [+50]",
        "funder": "undefined",
        "lastUpdated": "2020-08-28T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-bacterial-vector",
        "trimedName": "farmacológicos-veterinarios-sac-(farvet-sac)-universidad-peruana-cayetano-heredia-(upch)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD protein (baculovirus production) + F… [+20]",
        "developerResearcher": "Farmacológicos Veterinarios SAC (FARVET … [+50]",
        "funder": "undefined",
        "lastUpdated": "2020-08-28T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "farmacológicos-veterinarios-sac-(farvet-sac)-universidad-peruana-cayetano-heredia-(upch)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Spike protein; VaxiPatch microneedle arr… [+15]",
        "developerResearcher": "Verndari/ University of California, Davi… [+1]",
        "funder": "Biomedical Advanced Research and Develop… [+77]",
        "lastUpdated": "2020-08-27T00:00:00.000Z",
        "nextSteps": "Preliminary pre-clinical results are exp… [+131]",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "verndari-university-of-california-davis"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "CiVax™ COVID-19 vaccine candidate; spike… [+25]",
        "developerResearcher": "Soligenix/ University of Hawaii at Mānoa… [+0]",
        "funder": "Soligenix, Inc.",
        "lastUpdated": "2020-08-27T00:00:00.000Z",
        "nextSteps": "Pre-clinical testing results released in… [+10]",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "soligenix-university-of-hawaii-at-mānoa"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant fusion protein of the SARS-C… [+57]",
        "developerResearcher": "Sorrento Therapeutics",
        "funder": "undefined",
        "lastUpdated": "2020-08-17T00:00:00.000Z",
        "nextSteps": "Animal study results released July 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "sorrento-therapeutics"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit (gp-96 backbone)",
        "developerResearcher": "Heat Biologics (Zolovax)/ University of … [+31]",
        "funder": "undefined",
        "lastUpdated": "2020-08-13T00:00:00.000Z",
        "nextSteps": "Animal data released August 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "heat-biologics-(zolovax)-university-of-miami-waisman-biomanufacturing"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Adeno5-based",
        "developerResearcher": "Erciyes University",
        "funder": "undefined",
        "lastUpdated": "2020-08-03T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "erciyes-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "mRNA (ARCoV)",
        "developerResearcher": "People's Liberation Army (PLA) Academy o… [+35]",
        "funder": "undefined",
        "lastUpdated": "2020-08-03T00:00:00.000Z",
        "nextSteps": "Phase I trial began end of June 2020",
        "phase": "Phase I",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "peoples-liberation-army-(pla)-academy-of-military-sciences-walvax-biotech"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit",
        "developerResearcher": "Research\n  Institute for Biological Safe… [+30]",
        "funder": "undefined",
        "lastUpdated": "2020-08-03T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "research-institute-for-biological-safety-problems-rep-of-kazakhstan"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP",
        "developerResearcher": "Bezmialem Vakif University",
        "funder": "undefined",
        "lastUpdated": "2020-07-21T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "bezmialem-vakif-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "Self-amplifying\n  RNA",
        "developerResearcher": "Gennova",
        "funder": "undefined",
        "lastUpdated": "2020-07-15T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "gennova"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD-protein",
        "developerResearcher": "Mynvax",
        "funder": "undefined",
        "lastUpdated": "2020-07-15T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "mynvax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Spike-based (epitope screening)",
        "developerResearcher": "ImmunoPrecise/ LiteVax BV",
        "funder": "TRANSVAC2",
        "lastUpdated": "2020-07-15T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "immunoprecise-litevax-bv"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "VSV-S",
        "developerResearcher": "Aurobindo",
        "funder": "undefined",
        "lastUpdated": "2020-07-15T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "aurobindo"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP (CoVLP)+ Adjuvant",
        "developerResearcher": "Medicago\n  Inc./ GSK",
        "funder": "undefined",
        "lastUpdated": "2020-07-14T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "medicago-inc.-gsk"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP (CoVLP)+ Adjuvant (CpG 1018)",
        "developerResearcher": "Medicago Inc./ Dynavax",
        "funder": "undefined",
        "lastUpdated": "2020-07-10T00:00:00.000Z",
        "nextSteps": "Phase I to start mid-July 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "medicago-inc.-dynavax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Adenovirus-based",
        "developerResearcher": "Ankara University",
        "funder": "undefined",
        "lastUpdated": "2020-07-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "ankara-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Live attenuated virus",
        "description": "Codon deoptimized live attenuated vaccin… [+2]",
        "developerResearcher": "Mehmet Ali Aydinlar University/ Acıbadem… [+28]",
        "funder": "undefined",
        "lastUpdated": "2020-07-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "live-attenuated-virus",
        "trimedName": "mehmet-ali-aydinlar-university-acıbadem-labmed-health-services-a.s."
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated (inactivated + alum)",
        "developerResearcher": "KM Biologics",
        "funder": "undefined",
        "lastUpdated": "2020-07-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "km-biologics"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, TaliCoVax19",
        "developerResearcher": "InnoMedica",
        "funder": "undefined",
        "lastUpdated": "2020-07-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "innomedica"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP",
        "developerResearcher": "Middle East Technical University",
        "funder": "undefined",
        "lastUpdated": "2020-07-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "middle-east-technical-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Peptide + novel adjuvant",
        "developerResearcher": "Bogazici University",
        "funder": "undefined",
        "lastUpdated": "2020-07-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "bogazici-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP (COVID-19 and SARS1)",
        "developerResearcher": "OSIVAX",
        "funder": "European Innovation Council (EIC)",
        "lastUpdated": "2020-07-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "osivax"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "mRNA",
        "developerResearcher": "Selcuk University",
        "funder": "undefined",
        "lastUpdated": "2020-07-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "selcuk-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Sendai virus vector",
        "developerResearcher": "ID Pharma",
        "funder": "undefined",
        "lastUpdated": "2020-07-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "id-pharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Recombinant S protein",
        "developerResearcher": "Izmir Biomedicine and Genome Center",
        "funder": "undefined",
        "lastUpdated": "2020-07-09T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "izmir-biomedicine-and-genome-center"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector; measles vector… [+0]",
        "developerResearcher": "Zydus Cadila Healthcare Limited",
        "funder": "undefined",
        "lastUpdated": "2020-07-08T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "zydus-cadila-healthcare-limited"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "S subunit intranasal liposomal formulati… [+23]",
        "developerResearcher": "University of Virginia",
        "funder": "undefined",
        "lastUpdated": "2020-07-08T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "university-of-virginia"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP; unknown",
        "developerResearcher": "Doherty Institute",
        "funder": "undefined",
        "lastUpdated": "2020-07-08T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "doherty-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated (Inactivated + CpG 1018), VL… [+5]",
        "developerResearcher": "Valneva/ Dynavax",
        "funder": "undefined",
        "lastUpdated": "2020-07-08T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "valneva-dynavax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Live attenuated virus",
        "description": "MV-014-210",
        "developerResearcher": "Meissa Vaccines",
        "funder": "undefined",
        "lastUpdated": "2020-07-02T00:00:00.000Z",
        "nextSteps": "Start Phase 1 beginning of 2021",
        "phase": "Pre-clinical",
        "trimedCategory": "live-attenuated-virus",
        "trimedName": "meissa-vaccines"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated whole virus",
        "developerResearcher": "National Research Centre, Egypt",
        "funder": "undefined",
        "lastUpdated": "2020-06-30T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "national-research-centre-egypt"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; plasmid vaccine S, S1, S2, RBD \u0026 N",
        "developerResearcher": "National\n  Research Centre, Egypt",
        "funder": "undefined",
        "lastUpdated": "2020-06-30T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "national-research-centre-egypt"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP + Adjuvant",
        "developerResearcher": "Mahidol University/ The Government Pharm… [+46]",
        "funder": "undefined",
        "lastUpdated": "2020-06-30T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "mahidol-university-the-government-pharmaceutical-organization-(gpo)-siriraj-hospital"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Influenza A H1N1 vector",
        "developerResearcher": "National\n  Research Centre, Egypt",
        "funder": "undefined",
        "lastUpdated": "2020-06-30T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "national-research-centre-egypt"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "undefined",
        "developerResearcher": "Adeleke University",
        "funder": "undefined",
        "lastUpdated": "2020-06-30T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "adeleke-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein Subunit S, N, M \u0026 S1 protein",
        "developerResearcher": "National\n  Research Centre, Egypt",
        "funder": "undefined",
        "lastUpdated": "2020-06-30T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "national-research-centre-egypt"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Subunit",
        "developerResearcher": "Helix Biogen Consult, Ogbomoso \u0026 Trinity… [+57]",
        "funder": "undefined",
        "lastUpdated": "2020-06-30T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "helix-biogen-consult-ogbomoso-\u0026-trinity-immonoefficient-laboratory,-ogbomoso,-oyo-state,-nigeria"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Measles virus (S, N targets)",
        "developerResearcher": "DZIF - German Center for Infection Resea… [+16]",
        "funder": "undefined",
        "lastUpdated": "2020-06-30T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "dzif-german-center-for-infection-research-canvirex-ag"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "S protein integrated in HIV VLPs",
        "developerResearcher": "IrsiCaixa AIDS Research/ IRTA-CReSA/ Bar… [+37]",
        "funder": "undefined",
        "lastUpdated": "2020-06-23T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "irsicaixa-aids-research-irta-cresa-barcelona-supercomputing-centre-grifols"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Plant-based subunit (RBD-Fc + Adjuvant)",
        "developerResearcher": "Baiya Phytopharm/ Chula Vaccine Research… [+7]",
        "funder": "undefined",
        "lastUpdated": "2020-06-18T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "baiya-phytopharm-chula-vaccine-research-center"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "unknown; IMT504 technology",
        "developerResearcher": "NidoVax",
        "funder": "undefined",
        "lastUpdated": "2020-06-18T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "nidovax"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "Self amplifying RNA, self-assembling del… [+12]",
        "developerResearcher": "Chimeron Bio/ George Mason University's … [+54]",
        "funder": "undefined",
        "lastUpdated": "2020-06-17T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "chimeron-bio-george-mason-universitys-national-center-for-biodefense-and-infectious-disease"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "nanoparticles (vaults) as second-line de… [+18]",
        "developerResearcher": "Vault Pharma/ University of California L… [+10]",
        "funder": "undefined",
        "lastUpdated": "2020-06-17T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "vault-pharma-university-of-california-los-angeles"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit",
        "developerResearcher": "University of San Martin and CONICET, Ar… [+7]",
        "funder": "undefined",
        "lastUpdated": "2020-06-12T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "university-of-san-martin-and-conicet-argentina"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Outer Membrane Vesicle (OMV)-subunit",
        "developerResearcher": "Intravacc/Epivax",
        "funder": "undefined",
        "lastUpdated": "2020-06-12T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "intravaccepivax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "exoVACC exome platform",
        "developerResearcher": "Codiak BioSciences/ Ragon Institute",
        "funder": "undefined",
        "lastUpdated": "2020-06-04T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "codiak-biosciences-ragon-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "AAVCOVID, Adeno-associated viral vector … [+20]",
        "developerResearcher": "Massachusetts Eye and Ear/ AveXis, a Nov… [+59]",
        "funder": "undefined",
        "lastUpdated": "2020-06-02T00:00:00.000Z",
        "nextSteps": "Phase 1 to begin second half of 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "massachusetts-eye-and-ear-avexis-a-novartis-company-viralgen-aldevron-catalent-penn-medicine"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "Chimeric vaccine (coronavirus and influe… [+4]",
        "developerResearcher": "Vivaldi Biosciences/ Esco Aster Pte Ltd",
        "funder": "undefined",
        "lastUpdated": "2020-06-02T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "vivaldi-biosciences-esco-aster-pte-ltd"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "PDS-0203; Versamune T-cell activating te… [+8]",
        "developerResearcher": "PDS Biotechnology",
        "funder": "undefined",
        "lastUpdated": "2020-06-02T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "pds-biotechnology"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD protein fused with Fc of IgG + Adjuv… [+3]",
        "developerResearcher": "Chulalongkorn University/ GPO, Thailand",
        "funder": "undefined",
        "lastUpdated": "2020-06-01T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "chulalongkorn-university-gpo-thailand"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "MVA-S",
        "developerResearcher": "IDIBAPS- Hospital Clinic, Spain",
        "funder": "undefined",
        "lastUpdated": "2020-06-01T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "idibaps-hospital-clinic--spain"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "mRNA",
        "developerResearcher": "IDIBAPS- Hospital Clinic, Spain",
        "funder": "undefined",
        "lastUpdated": "2020-06-01T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "idibaps-hospital-clinic--spain"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Inactivated Flu-based SARS-CoV2 vaccine … [+10]",
        "developerResearcher": "National Center for Genetic Engineering … [+41]",
        "funder": "undefined",
        "lastUpdated": "2020-06-01T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "national-center-for-genetic-engineering-and-biotechnology-(biotec)-gpo-thailand"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "Virus-like particles, lentivirus, and ba… [+18]",
        "developerResearcher": "Navarrabiomed, Oncoimmunology group",
        "funder": "undefined",
        "lastUpdated": "2020-06-01T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "navarrabiomed-oncoimmunology-group"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Attenuated Influenza expressing an antig… [+33]",
        "developerResearcher": "Fundacao Oswaldo Cruz and Instituto Bunt… [+5]",
        "funder": "undefined",
        "lastUpdated": "2020-05-27T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "fundacao-oswaldo-cruz-and-instituto-buntantan"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Structurally modified spherical particle… [+35]",
        "developerResearcher": "Lomonosov Moscow State University",
        "funder": "undefined",
        "lastUpdated": "2020-05-27T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "lomonosov-moscow-state-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit EPV-CoV-19",
        "developerResearcher": "EpiVax",
        "funder": "undefined",
        "lastUpdated": "2020-05-27T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "epivax"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; mRNA lipid nanoparticle (mRNA-LNP)",
        "developerResearcher": "CanSino Biologics/Precision Nanosystems",
        "funder": "undefined",
        "lastUpdated": "2020-05-21T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "cansino-biologicsprecision-nanosystems"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Avian paramyxovirus vector (APMV)",
        "developerResearcher": "The Lancaster University, UK",
        "funder": "undefined",
        "lastUpdated": "2020-05-19T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "the-lancaster-university-uk"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLPs peptides/whole virus",
        "developerResearcher": "University of Sao Paulo",
        "funder": "undefined",
        "lastUpdated": "2020-05-19T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "university-of-sao-paulo"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Newcastle disease virus vector (NDV-SARS… [+13]",
        "developerResearcher": "Intravacc/ Wageningen Bioveterinary Rese… [+18]",
        "funder": "undefined",
        "lastUpdated": "2020-05-19T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "intravacc-wageningen-bioveterinary-researchutrecht-univ."
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector; horsepox vecto… [+32]",
        "developerResearcher": "Tonix Pharma / Southern Research",
        "funder": "undefined",
        "lastUpdated": "2020-05-19T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "tonix-pharma-southern-research"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Outer Membrane Vesicle (OMV)-peptide",
        "developerResearcher": "Intravacc/Epivax",
        "funder": "undefined",
        "lastUpdated": "2020-05-19T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "intravaccepivax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "RBD-based",
        "developerResearcher": "Neovii/Tel Aviv University",
        "funder": "undefined",
        "lastUpdated": "2020-05-19T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "neoviitel-aviv-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "AVI-205",
        "developerResearcher": "AbVision",
        "funder": "undefined",
        "lastUpdated": "2020-05-13T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "abvision"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "OMV-based vaccine",
        "developerResearcher": "BiOMVis Srl/ University of Trento",
        "funder": "undefined",
        "lastUpdated": "2020-05-12T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "biomvis-srl-university-of-trento"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "OMV-based vaccine",
        "developerResearcher": "Quadram Institute Biosciences",
        "funder": "undefined",
        "lastUpdated": "2020-05-12T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "quadram-institute-biosciences"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Orally delivered, heat stable subunit",
        "developerResearcher": "Applied Biotechnology Institute, Inc.",
        "funder": "undefined",
        "lastUpdated": "2020-05-12T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "applied-biotechnology-institute-inc."
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "mRNA\n",
        "developerResearcher": "Greenlight Biosciences\n",
        "funder": "undefined",
        "lastUpdated": "2020-05-12T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "greenlight-biosciences-"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "LV-SMENP-DC Dendritic cells modified wit… [+153]",
        "developerResearcher": "Shenzhen Geno-Immune Medical Institute",
        "funder": "undefined",
        "lastUpdated": "2020-05-12T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "shenzhen-geno-immune-medical-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "Artificial antigen-presenting cells modi… [+101]",
        "developerResearcher": "Shenzhen Geno-Immune Medical Institute",
        "funder": "undefined",
        "lastUpdated": "2020-05-12T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "shenzhen-geno-immune-medical-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; recombinant protein vac… [+63]",
        "developerResearcher": "UMN Pharma (Shionogi)",
        "funder": "Japan Agency for Medical Research and De… [+9]",
        "lastUpdated": "2020-05-10T00:00:00.000Z",
        "nextSteps": "Phase I to start by end of 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "umn-pharma-(shionogi)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating bacterial vector",
        "description": "Recombinant LVS ΔcapB – vectored vaccine… [+40]",
        "developerResearcher": "University of California, Los Angeles (H… [+11]",
        "funder": "undefined",
        "lastUpdated": "2020-05-10T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-bacterial-vector",
        "trimedName": "university-of-california-los-angeles-(horwitz-lab)"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; mRNA in an intranasal delivery syst… [+73]",
        "developerResearcher": "eTheRNA Immunotherapies / EpiVax/ Nexeli… [+84]",
        "funder": "undefined",
        "lastUpdated": "2020-05-04T00:00:00.000Z",
        "nextSteps": "Start Phase I early 2021",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "etherna-immunotherapies-epivax-nexelis-reprocell--centre-for-the-evaluation-of-vaccination-of-the-university-of-antwerp"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector; YF17D Vector",
        "developerResearcher": "KU Leuven",
        "funder": "undefined",
        "lastUpdated": "2020-05-04T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "ku-leuven"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, recombinant S1-Fc fusio… [+9]",
        "developerResearcher": "AnyGo Technology",
        "funder": "undefined",
        "lastUpdated": "2020-05-04T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "anygo-technology"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Oral Ad5 S",
        "developerResearcher": "Stabilitech Biopharma Ltd",
        "funder": "undefined",
        "lastUpdated": "2020-05-04T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "stabilitech-biopharma-ltd"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, nanoparticle vaccine",
        "developerResearcher": "LakePharma, Inc.",
        "funder": "undefined",
        "lastUpdated": "2020-05-04T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "lakepharma-inc."
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP; eVLP",
        "developerResearcher": "ARTES Biotechnology\n",
        "funder": "undefined",
        "lastUpdated": "2020-05-04T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "artes-biotechnology-"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; several mRNA candidates",
        "developerResearcher": "RNAimmune, Inc.",
        "funder": "undefined",
        "lastUpdated": "2020-05-04T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "rnaimmune-inc."
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, recombinant protein",
        "developerResearcher": "Yisheng Biopharma",
        "funder": "undefined",
        "lastUpdated": "2020-05-04T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "yisheng-biopharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "M2-deficient single replication (M2SR) i… [+15]",
        "developerResearcher": "University of Wisconsin-Madison / FluGen… [+16]",
        "funder": "undefined",
        "lastUpdated": "2020-05-04T00:00:00.000Z",
        "nextSteps": "Start Phase I trial in fall 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "university-of-wisconsin-madison-flugen-bharat-biotech"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Adenovirus-based + HLA-matched peptides … [+12]",
        "developerResearcher": "Valo Therapeutics Ltd",
        "funder": "undefined",
        "lastUpdated": "2020-05-04T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "valo-therapeutics-ltd"
    },
    {
        "FDAApproved": "undefined",
        "category": "Live attenuated virus",
        "description": "Codon deoptimized live attenuated virus",
        "developerResearcher": "Indian Immunologicals Ltd/ Griffith Univ… [+6]",
        "funder": "undefined",
        "lastUpdated": "2020-04-28T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "live-attenuated-virus",
        "trimedName": "indian-immunologicals-ltd-griffith-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated + adjuvant (CpG 1018)",
        "developerResearcher": "Sinovac/ Dynavax",
        "funder": "undefined",
        "lastUpdated": "2020-04-28T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "sinovac-dynavax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Live attenuated virus",
        "description": "Codon deoptimized live attenuated virus",
        "developerResearcher": "Codagenix / Serum Institute of India",
        "funder": "undefined",
        "lastUpdated": "2020-04-28T00:00:00.000Z",
        "nextSteps": "Animal data in summer 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "live-attenuated-virus",
        "trimedName": "codagenix-serum-institute-of-india"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; parainflue… [+61]",
        "developerResearcher": "University of Georgia/ University of Iow… [+1]",
        "funder": "undefined",
        "lastUpdated": "2020-04-28T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "university-of-georgia-university-of-iowa"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; plant virus nanotechnol… [+50]",
        "developerResearcher": "University of California, San Diego",
        "funder": "National Science Foundation (Rapid Respo… [+27]",
        "lastUpdated": "2020-04-28T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "university-of-california-san-diego"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; ZIP-1642, vaccine consists of a com… [+65]",
        "developerResearcher": "Ziphius Therapeutics/ Ghent University",
        "funder": "undefined",
        "lastUpdated": "2020-04-28T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "ziphius-therapeutics-ghent-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "undefined",
        "developerResearcher": "Emergex Vaccines/ George Mason Universit… [+66]",
        "funder": "undefined",
        "lastUpdated": "2020-04-24T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "emergex-vaccines-george-mason-universitys-national-center-for-biodefense-and-infectious-diseases-(ncbid)"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "undefined",
        "developerResearcher": "Catholic University/ Millennium Institut… [+100]",
        "funder": "undefined",
        "lastUpdated": "2020-04-23T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "catholic-university-millennium-institute-of-immunology-and-immunotherapy-technological-consortium-in-clinical-molecular-biomedicine-chile"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "Self-assembling vaccine (fusion protein … [+75]",
        "developerResearcher": "HaloVax (Voltron Therapeutics) / The Vac… [+65]",
        "funder": "Analog Devices Foundation",
        "lastUpdated": "2020-04-21T00:00:00.000Z",
        "nextSteps": "Animal study results by October 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "halovax-(voltron-therapeutics)-the-vaccine-\u0026-immunotherapy-center-at-the-massachusetts-general-hospital"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, S protein + adjuvant",
        "developerResearcher": "National Institute of Infectious Disease… [+7]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "national-institute-of-infectious-disease-japan"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; S protein",
        "developerResearcher": "EpiVax / University of Georgia",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "epivax-university-of-georgia"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; MVA encode… [+5]",
        "developerResearcher": "GeoVax / BravoVax",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "geovax-bravovax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; spike based",
        "developerResearcher": "University of Alberta",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "university-of-alberta"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "ISR-50",
        "developerResearcher": "ISR Immune System Regulation",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "Animal study results expected in Q2 2020… [+24]",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "isr-immune-system-regulation"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; peptide",
        "developerResearcher": "Vaxil Bio",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "vaxil-bio"
    },
    {
        "FDAApproved": "undefined",
        "category": "DNA-based",
        "description": "DNA; plasmid vaccine, needle-free delive… [+2]",
        "developerResearcher": "Immunomic Therapeutics/ EpiVax/ PharmaJe… [+1]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "dna-based",
        "trimedName": "immunomic-therapeutics-epivax-pharmajet"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA",
        "developerResearcher": "GeneOne Life Science / Houston Methodist… [+0]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "geneone-life-science-houston-methodist"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "PittCoVacc, Protein subunit, microneedle… [+18]",
        "developerResearcher": "University of Pittsburgh",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "Phase I to start as early as June 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "university-of-pittsburgh"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, recombinant protein, na… [+51]",
        "developerResearcher": "St. Petersburg Scientific Research Insti… [+27]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "st.-petersburg-scientific-research-institute-of-vaccines-and-serums"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; liposome-encapsulated mRNA",
        "developerResearcher": "BiOCAD",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "Animal studies began April 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "biocad"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; S protein",
        "developerResearcher": "AJ Vaccines",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "aj-vaccines"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "undefined",
        "developerResearcher": "SK Biosciences",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "sk-biosciences"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; oral E. coli-based prot… [+41]",
        "developerResearcher": "MIGAL Galilee Research Institute",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "migal-galilee-research-institute"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; adjuvanted protein subu… [+9]",
        "developerResearcher": "Biological E Ltd",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "biological-e-ltd"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP; ADDomerTM multiepitope display",
        "developerResearcher": "Imophoron Ltd / Bristol University's Max… [+14]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "imophoron-ltd-bristol-universitys-max-planck-centre"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "undefined",
        "developerResearcher": "Precision Vaccines Program at Boston Chi… [+16]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "precision-vaccines-program-at-boston-childrens-hospital"
    },
    {
        "FDAApproved": "undefined",
        "category": "Inactivated virus",
        "description": "Inactivated",
        "developerResearcher": "Osaka University / BIKEN / NIBIOHN",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "inactivated-virus",
        "trimedName": "osaka-university-biken--nibiohn"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "AdCOVID; single-dose, intranasal vaccine… [+81]",
        "developerResearcher": "Altimmune / University of Alabama at Bir… [+7]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "Phase I trial to begin Q3 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "altimmune-university-of-alabama-at-birmingham"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, peptide",
        "developerResearcher": "Flow Pharma",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "flow-pharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; mRNA",
        "developerResearcher": "China CDC / Tongji University / Stermina… [+0]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "china-cdc-tongji-university--stermina"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector; Ad5 S (GRE… [+14]",
        "developerResearcher": "Greffex",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "greffex"
    },
    {
        "FDAApproved": "undefined",
        "category": "Virus-like particle",
        "description": "VLP; virus-like particle, based on RBD d… [+31]",
        "developerResearcher": "Saiba GmbH",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "virus-like-particle",
        "trimedName": "saiba-gmbh"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; liposome-encapsulated mRNA",
        "developerResearcher": "BIOCAD",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "Animal studies begin in April 2020",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "biocad"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; COVID-19 XWG-03 truncat… [+17]",
        "developerResearcher": "Innovax / Xiamen University / GSK",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "innovax-xiamen-university--gsk"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; LNP-encapsulated mRNA cocktail enco… [+8]",
        "developerResearcher": "Fudan University / Shanghai JiaoTong Uni… [+27]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "fudan-university-shanghai-jiaotong-university--rnacure-biopharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; Ii-Key peptide",
        "developerResearcher": "Generex / EpiVax",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "generex-epivax"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, drosophila S2 insect ce… [+25]",
        "developerResearcher": "ExpreS2ion",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "expres2ion"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; Subunit protein, plant … [+8]",
        "developerResearcher": "iBio / CC-Pharming",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "ibio-cc-pharming"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; LNP-encapsulated mRNA cocktail enco… [+8]",
        "developerResearcher": "Fudan University / Shanghai JiaoTong Uni… [+27]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "fudan-university-shanghai-jiaotong-university--rnacure-biopharma"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "undefined",
        "developerResearcher": "Vir Biotechnology / GSK",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "vir-biotechnology-gsk"
    },
    {
        "FDAApproved": "undefined",
        "category": "Non-replicating viral vector",
        "description": "Non-replicating viral vector, MVA expres… [+24]",
        "developerResearcher": "Centro Nacional Biotecnologia (CNB-CSIC)… [+7]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "non-replicating-viral-vector",
        "trimedName": "centro-nacional-biotecnologia-(cnb-csic)-spain"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector; VSV-S",
        "developerResearcher": "University of Western Ontario",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "university-of-western-ontario"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector, live viral vec… [+71]",
        "developerResearcher": "BiOCAD/ IEM",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "biocad-iem"
    },
    {
        "FDAApproved": "undefined",
        "category": "RNA-based vaccine",
        "description": "RNA; Replicating defective SARS-CoV-2 de… [+10]",
        "developerResearcher": "Centro Nacional Biotecnologia (CNB-CSIC)… [+7]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "rna-based-vaccine",
        "trimedName": "centro-nacional-biotecnologia-(cnb-csic)-spain"
    },
    {
        "FDAApproved": "undefined",
        "category": "Replicating viral vector",
        "description": "Replicating viral vector, live viral vec… [+71]",
        "developerResearcher": "BIOCAD / IEM",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "replicating-viral-vector",
        "trimedName": "biocad-iem"
    },
    {
        "FDAApproved": "undefined",
        "category": "Other",
        "description": "undefined",
        "developerResearcher": "Tulane University",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "Other",
        "trimedName": "tulane-university"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, VLP-recombinant protein… [+11]",
        "developerResearcher": "Osaka University / BIKEN / National Inst… [+38]",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "osaka-university-biken--national-institutes-of-biomedical-innovation--japan"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit; S1 or RBD protein",
        "developerResearcher": "Baylor College of Medicine",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "baylor-college-of-medicine"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, adjuvanted microsphere … [+7]",
        "developerResearcher": "VIDO-InterVac, University of Saskatchewa… [+1]",
        "funder": "The Government of Saskatchewan and the C… [+26]",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "Animal testing results expected in April… [+5]",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "vido-intervac-university-of-saskatchewan"
    },
    {
        "FDAApproved": "undefined",
        "category": "Protein subunit",
        "description": "Protein subunit, synthetic long peptide … [+38]",
        "developerResearcher": "OncoGen",
        "funder": "undefined",
        "lastUpdated": "2020-04-20T00:00:00.000Z",
        "nextSteps": "undefined",
        "phase": "Pre-clinical",
        "trimedCategory": "protein-subunit",
        "trimedName": "oncogen"
    }
]
